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Rasgrf1 is imprinted and paternally-expressed in neonatal mouse brain.
At weaning, expression becomes biallelic.  Manipulating the elements
regulating imprinted Rasgrf1 expression produces mice with transient
perturbations in Rasgrf1 imprinting, which we can use to assay the
consequences of aberrant imprinting during a specific developmental time.
As neonates, monoallelic-paternal (wild-type) mice paternally express Rasgrf1;
biallelic mice express Rasgrf1 from both alleles; null mice do not express
Rasgrf1; and monoallelic-maternal mice reciprocally express Rasgrf1, from the
maternal allele.  This last genotype represents a unique opportunity to study
the effects of expression derived from either of the two parental alleles.  All
genotypes biallelically express Rasgrf1 around weaning.
Two phenotypes appear when Rasgrf1 imprinted is perturbed: a
difference in size, and a difference in performance on an associative odor-
learning task at postnatal day 8 (P8).  Size differences persist through
adulthood and reflect the level of Rasgrf1 expressed pre-weaning: biallelics are
larger, nulls are smaller, and the two monoallelically-expressing genotypes are
intermediate and indistinguishable from one another.  We determined that
neonatal Rasgrf1 expression affects the functioning of the growth
hormone/IGF-1 axis (GH/IGF-1 axis), with an input as far upstream as the
hypothalamus, and that Rasgrf1 helps to set growth parameters early in
development that persist through adulthood.  Importantly, these data are the
first experimental validation of one of the critical assumptions of the “conflict
hypothesis,” which describes the evolution of genomic imprinting in
mammals.
Imprinting perturbations at Rasgrf1 also produce performance
differences on an associative odor-learning task in P8 neonates.  The presence
of a wild-type paternal allele is critical for proper task performance, as null
mice, and those with maternally-derived Rasgrf1 expression, do not perform
as well.  These differences in neonatal performance are accompanied by
differences in Rasgrf1 expression level and alterations in the amount of
activated Ras and Rac protein in various brain structures.  Differences in
learning are not present in adult mice, suggesting that the role Rasgrf1 plays in
these phenotypes differs with respect to age, as well as the sensitivity of the
system to Rasgrf1 expression level.
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1I. INTRODUCTION
I.1.  Epigenetics
I.1.1 Definition
In 1942, Conrad Waddington described the result of genes interacting
with their surroundings as an “epigenetic landscape” – a metaphor for
processes occurring during developmental cellular differentiation
(Waddington, 1942). Originally, “epigenetics” was simply a portmanteau
comprised of “genetics” and “epigenesis,” and was defined as the process by
which genotypes produce phenotypes during development.  In the
intervening years, the definition of “epigenetics” has broadened to encompass
biological processes unrelated to development, as well as narrowed to focus
on non-mutational, heritable modifications that produce variant phenotypes.
Today, “epigenetics” refers to mechanisms that affect gene expression
independently of nucleotide mutations (Russo et al., 1996), meaning that
mutant phenotypes can be produced in the absence of sequence variation.
The mechanisms producing these changes in expression are stable and
heritable, yet reversible, and can be influenced by environmental factors such
as diet, maternal behavior, and toxins (Waterland and Jirtle, 2003; Weaver et
al., 2004; Anway et al., 2005), in addition to endogenous biological catalysts.
The consequences of epigenetic changes can persist through multiple rounds
of cell division, with the best-known example being the differentiation of
totipotent stem cells into pluripotent cell lines during normal embryonic
2development, since differentiation involves cells that are genetically identical
but epigenetically distinct (Bernstein et al., 2006).  On an organismal level, the
phenotypic consequences of epigenetic alterations can be penetrant through
multiple subsequent generations (reviewed in Jablonka and Raz, 2009; Anway
et al., 2005; Rakyan et al., 2003); phenotypes are then available for selection to
act upon, yet such epigenetic changes do not leave a detectable signature at
the sequence level, which suggests that such modifications may play a
significant – but difficult to detect – role in shaping evolutionary processes.
Epigenetic modifications exist in a number of organisms, including
fission yeast (Schizosaccharomyces pombe; Grewal and Klar, 1996), flowering
plants (Arabidopsis thaliana; Vongs et al., 1993), invertebrates (Drosophila
melanogaster; Cleard et al., 1997), and mammals (Mus musculus, Homo sapiens;
Li et al., 1993; Fraga et al., 2005).  Epigenetic mechanisms are essential for a
number of biological processes including cellular differentiation (reviewed in
Reik, 2007), paramutation (reviewed in Chandler, 2007), X-chromosome
inactivation (Panning & Jaenisch, 1996), genomic imprinting (Stoger et al.,
1993; Ferguson-Smith et al., 1993), transcription, and chromosome dynamics
(reviewed in Goll & Bestor, 2005).  Additionally, such modifications are
implicated in the production of a number of pathological states in humans,
including cancer, mental disorders, metabolic processes, and conditions
associated with aberrant genomic imprinting (ie, Prader-Willi and Angelman
syndromes; reviewed in Jaenisch & Bird, 2003).
3I.1.2 Modifications & Mechanisms
Epigenetic modifications include the covalent attachment of various
chemical groups to DNA itself or to the histone proteins around which DNA
is packaged.
I.1.2.1 DNA Methylation
In mammals, most DNA is methylated by the covalent attachment of a
methyl group to the 5’ carbon of a cytosine residue that occurs as part of a
CpG dinucleotide.  CpG dinucleotides are symmetric and can cluster to form
“islands,” which are sequences of DNA rich in CG residues as well as CpG
dinucleotides.  "Hemimethylated" DNA exists when one strand of DNA is
methylated, and the other is unmethylated; the methylated strand can serve as
a template for the proper placement of methyl groups on the other strand –
during DNA replication, for example.  DNA methylation is observed at CpG
islands, which are often present near promoters; methylation is also observed
within repetitive regions like satellite sequences and transposable elements,
and centromeres.  Hydroxymethylation of cytosine residues has recently been
reported to exist in mammalian neurons (Kriaucionis and Heintz, 2009),
though little is known about its distribution outside the brain.  DNA
methylation has also been observed and well-characterized in flowering
plants, though the pattern differs from that observed in mammals: in addition
to CpG dinucleotides, (symmetric) CpNpG and (asymmetric) CpNpN
sequences are also targets for methylation (Zilberman et al., 2007).  DNA
methylation has been identified at low levels in Drosophila and Neurospora,
though has not been detected in yeast or worm (Bull and Wootton, 1984;
4reviewed in Bird, 2002).  Additionally, non-CpG methylation has been
reported in mammals, with nearly one-quarter of methylation in human
embryonic stem cells present in a non-CpG context – though differentiation of
stem cells leads to the disappearance of non-CpG methylation (Lister et al.,
2009).
DNA methylation is catalyzed by a class of enzymes known as DNA
methyltransferases (DNMTs), which transfer a methyl group from the methyl
donor S-adenosylmethionine to the cytosine residue.  Several DNMTs have
been characterized in mammals:  Dnmt1, Dnmt3a, and Dnmt3b.  Mammalian
Dnmt1 mutants are embryonic lethal (Li et al., 1992), pointing to an important
role for DNA methylation in normal growth and development.  Dnmt1 is a
maintenance methyltransferase, meaning that it catalyzes reactions at
hemimethylated loci, while Dnmt3a and 3b are de novo methyltransferases,
capable of methylating a completely unmethylated strand of DNA.  The
conversion of 5-methylcytosine to 5-hydroxymethylcytosine can be
accomplished by the enzyme TET1, though this relationship has only been
demonstrated in cell culture and in vitro (Tahiliani et al., 2009).  The enzyme(s)
supporting the opposite reaction – the removal of a methyl group – has not
been well-characterized in vertebrates, but evidence for mechanisms exists.  In
Xenopus laevis oocytes, Gadd45a and the DNA repair endonuclease XPG are
involved in DNA repair-mediated demethylation that activates methylation-
silenced reporter plasmids (Barreto et al., 2007).  In zebrafish embryos,
injection of methylated DNA induces active demethylation, which is mediated
by a combination of Gadd45, a 5-methylcytosine deaminase (AID), and a G:T
mismatch-specific thymine glycosylase (Mbd4; Rai et al., 2008).  In mouse,
5Gadd45b-mediated demethylation has been demonstrated to occur in a
neuronal activity-dependent fashion in mature hippocampal neurons, which
links neural activity and processes involved in plasticity with epigenetic
remodeling (Ma et al., 2009). Demethylating enzymes have been identified and
characterized in Arabidopsis, and these enzymes – DME and ROS1 – act as
DNA glycosylases and apurinic/apyrimidinic lyases(Gehring et al., 2006;
Gong et al., 2006). Demethylation is an active and essential process during
mammalian development (Oswald et al., 2000; reviewed in Morgan et al.,
2005).
I.1.2.2 Histone Modifications
Histone proteins are targets for epigenetic marking, and modifications
affect higher-order chromatin structure and the transcriptional accessibility of
a locus.  Histones form an octamer comprised of four different subunits in
duplicate (H2A, H2B, H3, and H4), and when DNA is coiled around these
octamers the structure is known as a nucleosome; nucleosomes are then
organized and condensed to form chromosomes.  The amount of condensation
can vary: DNA supported by loosely packaged stretches of nucleosomes is
more transcriptionally accessible, while tightly coiled regions are more
difficult for transcriptional machinery to access.  Epigenetic modifications to
histone proteins work to produce these changes in chromatin structure by the
recruitment of chromatin remodeling factors and complexes, which work to
facilitate higher–order regulation of gene transcription (reviewed in Knoepfler
and Eisenman, 1999; Schulze & Wallrath, 2007).
6Commonly, histones are post-translationally modified at specific amino
acids in their N-terminal tails, which project outward from the core of the
nucleosome.  Modifiers are comprised of a broader class of chemical groups:
in addition to methylation, histones can be acetylated, phosphorylated,
ubiquitinated, ribosylated, and sumolated.  Chromatin conformation is
regionally affected by modifications to histone proteins: an abundance of
silencing or activating marks in an area can create either a transcriptionally-
repressed (closed) chromatin conformation, or a transcriptionally-active
(open) conformation.  Not surprisingly, the predominance of these marks
varies along the length of a chromosome, with centromeric and condensed
(heterochromatic) regions being characterized by a set of marks that differs
from those found in less tightly-packed (euchromatic) areas.  Additionally,
marks can exist in different patterns during development, and different
distributions of histone modifications are coincident with processes like
cellular differentiation (Bernstein et al., 2006), and can mark different cell
lineages (Mikkelsen et al., 2007).
I.1.3 Effects of Epigenetic Marks on Transcription
The specific effect of a modification on expression cannot readily be
predicted by the type of modification present.  Rather, the location of the
modification within either the DNA sequence or at a specific histone residue
determines whether the mark will act to silence or promote gene expression;
in some cases, even the number of groups attached has significant functional
importance.
7For example, methyl groups placed on DNA close to a gene’s promoter
may act as repressive elements – indeed, DNA methylation is thought to have
evolved as a mechanism for silencing transposable elements and foreign DNA
insertions (reviewed in Slotkin & Martienssen, 2007).  DNA methylation at
gene promoters can recruit methylated-CpG binding proteins (MBDs), which
in turn can recruit corepressors, remodeling complexes, and histone
deacetylases (HDACs), which all act in concert to create a repressive
chromatin conformation at a locus (Boyes & Bird, 1991; Nan et al., 1998;
Dobosy & Selker, 2001).
However, methyl groups placed within a regulatory sequence can
facilitate transcription of a gene, a pattern observed at the Rasgrf1 locus in
mouse (Yoon et al., 2002; Yoon et al., 2005).  At this locus, DNA methylation
prevents the binding of CCCTC binding factor (CTCF), a methylation-
sensitive enhancer-blocking protein that is highly conserved among taxa.
When CTCF is bound to a sequence, it can block promoter-enhancer
interaction and thus leads to transcriptional silencing.  A second major
function of CTCF in the genome is to act as an insulator, preventing the spread
of heterochromatin (Bell et al., 1999; reviewed in Ohlsson et al., 2001).
Modifier groups placed on histone proteins have different effects
depending both on the placement and the number of marks present;
modification of lysine residues has been the most extensively profiled, with
acetylation generally acting to increase transcriptional accessibility of a locus,
and methylation having varied effects on expression.  For example,  ‘silencing’
8marks include trimethylated lysine 9 on histone H3 (H3K9me3), trimethylated
lysine 20 on histone H4 (H4K20me3), and trimethylated lysine 27 on histone
H3 (H3K27me3), and ‘activating’ marks include trimethylated lysine 4 on
histone H3 (H3K4me3) and trimethylated lysine 36 on histone H4
(H4K36me3); additionally, monomethylated H3K9 is associated with
transcribed regions, meaning that even the number of methyl marks placed
can have different effects (Peterson & Laniel,  2004; Li et al., 2007; Barski et al.,
2007).  Often, marks compete with one another for placement and overall
effect on transcription within a certain region, an observation that has led to
the development of the ‘histone code’ which identifies histone modifications
as mediating the interaction between chromatin, DNA, and transcriptional
status  (Jenuwein & Allis 2001).  Also of importance is the hierarchical
relationship between the placement of DNA methylation and histone
modifications, with the suggestion of mutual exclusion and antagonism
existing for some types of marks: for example, DNA methylation and H3K27
trimethylation (H3K27me3) cannot exist at the same sequence at the Rasgrf1
locus, as placement of one mark prevents placement of the other mark
(Lindroth et al., 2008).
I.1.4 Environmental Inputs and Disease States
Epigenetic mechanisms confer a certain amount of genomic flexibility
in that they can be inherited in non-Mendelian ratios, are sensitive to a variety
of environmental inputs, and reversibly affect gene expression.  Indeed, such
mechanisms are postulated to form one of the links connecting gene
9expression with environmental contributions.  However, aberrant placement
of epigenetic marks can lead to disease states – in model organisms as well as
in humans – and the placement of these marks can persist through multiple
generations, affecting the fitness of individuals in the absence of the initial
stimulus.
Diet and toxins have been observed to significantly and
transgenerationally affect epigenetic modifications.  For example, gestating
rats transiently exposed to the fungicide vinclozolin produce an F1 generation
with reported genome-wide changes in DNA methylation, and aberrant
phenotypes – which include increased rates of male infertility and a decrease
in spermatogenic capacity – are observed four generations post-exposure
(Anway et al., 2005).  Feeding a methyl-supplemented diet to gestating viable
yellow agouti (A(vy)) mice leads to DNA methylation at the A(vy) locus
(termed a 'metastable epiallele') in progeny, which persists through adulthood
and produces phenotypic alterations (Waterland & Jirtle, 2003).  Similar effects
are observed at the Axin-Fused (Axin(Fu)) locus in mouse, another metastable
epiallele, with methyl-supplemented maternal diets producing aberrant
patterns of DNA methylation (and altered phenotypes) in progeny (Waterland
et al., 2006).  Both the A(vy) and Axin(fu) loci contain a retrotransposon-
derived intracisternal A particle (IAP), which may make these loci especially
susceptible to diet-induced changes in methylation.  Pregnant rats exposed to
a low-protein diet produced progeny with reduced DNA methylation at
specific loci; supplementing that low-protein diet with folic acid prevented
alterations in DNA methylation (Lillycrop et al., 2005), which otherwise
persisted through adulthood (Lillycrop et al., 2008).  Additionally, the
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incidence of mortality due to cardiovascular disease and diabetes has been
epidemiologically shown to correlate with both parental and grandparental
nutrition state in humans  (Kaati et al., 2002), suggesting that a mechanism not
unlike those observed in rodents might be affecting the expression of genes
responsible for producing these disease states.
Evidence in rats suggests that maternal behavior can affect the
epigenetic state of sensitive loci in offspring.  Variability in the grooming
styles of female rats was demonstrated to affect DNA methylation, histone
acetylation, and transcription factor binding at the glucocorticoid receptor in
progeny (Weaver et al., 2004).  Exposure later in life to a diet high in methyl-
donors reversed the early effects of maternal behavior on the epigenome
(Weaver et al., 2005), suggesting again that such epigenetic modifications are
sensitive to environmental inputs and confer a higher level of genomic
plasticity than sequence alone is capable of.
The aberrant placement of epigenetic marks produces diseases in
humans as well as in model organisms.  Perhaps the most-studied example of
such processes is cancer,  with the first demonstration of a link between DNA
methylation and cancer occurring over two decades ago (Feinberg &
Vogelstein, 1983).  More recently,  the role of epigenetic processes in cognitive
function and disorder is beginning to be elucidated.  Epigenetic factors are
postulated to play a part in the presentation of such conditions as Alzheimer's
disease and Rett syndrome (reviewed in Graff & Mansuy, 2009), a variety of
mental retardation disorders (reviewed in Urdinguio et al., 2009), drug
addiction and depression (reviewed in Renthal & Nestler, 2009), schizophrenia
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(Roth et al., 2009), and post-traumatic stress disorder (Yehuda & Bierer, 2009),
suggesting that the phenotypic effects of epigenetic marks are present in
organisms at all levels, from the beginning of embryonic development to
neurodegeneration in later life.
I.2.  Genomic Imprinting
Genomic imprinting in mammals refers to the proscribed allele-specific
expression of a gene, with transcriptional activity determined by the parent
from which an allele is inherited.  Some genes are only expressed from the
maternal allele – with corresponding silencing of the paternal allele – and
some are expressed in the opposite pattern (reviewed in Delaval & Feil, 2004;
Wilkins & Haig, 2003).  Imprinting exists at a small subset of mammalian
genes – to date, there are only around 100 imprinted genes identified in
mouse, though a larger number are predicted to be imprinted based on
sequence features (Luedi et al., 2007), and still more predicted, and validated,
based on the clustering of various epigenetic marks (Brideau et al., submitted,
2009).  Imprinting has been identified in mammals, marsupials, and plants
(Weidman et al.,2004; Suzuki et al.,2005; Edwards et al., 2007, Martienssen et al.,
2008), with suggestions of imprinting-like processes in social insects (Queller,
2003; Kronauer, 2008; Elango et al., 2009).
Imprinting at a locus can be more complicated than monoallelic
transcription in all tissues at all ages.  In some cases, imprinted expression is
restricted to a specific type of tissue or developmental stage.  In the case of
Igf2r, for example, maternal-specific expression occurs in non-neuronal cells
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within the mouse brain and other somatic tissues throughout the organism,
but in neurons, expression is biallelic (Barlow et al., 1991; Hu et al., 1998;
Yamasaki et al., 2005).  In mouse, Ube3a is maternally-expressed in neurons but
biallelically-expressed in other somatic tissues (Yamasaki et al., 2003), while
Grb10 is predominantly paternally-expressed in brain, but maternally-
expressed in other somatic tissues (Hikichi et al., 2003).  Additionally,
imprinting at a locus may vary with developmental stage:  Murr1 is imprinted
in adult mouse brain, but biallelically expressed in embryonic and neonatal
brain tissue (Wang et al., 2004), while Rasgrf1 is paternally-expressed in
neonatal mouse brain, but gradually transitions to biallelic expression around
the time of weaning (Plass et al., 1996, Drake et al., 2009).  Other loci are only
imprinted in the placenta (reviewed in Wagschal & Feil, 2006).
I.2.1 Epigenetic Regulation of Imprinting
Allele-specific epigenetic patterns accompany the allele-specific
expression characteristic of imprinting (Mager & Bartolomei, 2005; Edwards &
Ferguson-Smith, 2007).  Placement of these marks occurs in the germline, and
the developing organism retains these parental marks in somatic tissues, yet
reprograms its germline to reflect its own sex (reviewed in Santos & Dean,
2004;  Morgan, 2005; Reik, 2007).  Reprogramming and the mechanisms that
regulate it are being extensively studied, as similar mechanisms may be
responsible for the aberrant placement of epigenetic marks that result in
disease states associated with misimprinting, as well as in the development of
cancer cells and the regulation of their growth and immortality (Robertson,
2005).
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I.2.1.1 DNA methylation
Allele-specific methylation patterns are observed at the imprinting
control regions (ICRs) that govern imprinted expression, and in mouse, all but
three loci (Rasgrf1, H19/Igf2, Dlk1/Gtl1) exhibit maternal-allele specific
methylation.  Imprinted genes tend to occur in clusters throughout the
genome, and one ICR can affect the imprinted expression of multiple genes
(reviewed in Reik & Walter, 2001).  Methylation can act to impart imprinted
expression by affecting the activity of enhancer-blocking elements (at the
H19/Igf2 locus, Bell & Felsenfeld, 2000; at the Rasgrf1 locus, Yoon et al., 2005),
the transcription of antisense non-coding RNAs (ncRNAs;  Igf2r/Air
transcript, Sleutels et al., 2002; Kcnq1/Kcnq1ot1, Mancini-Dinardo et al., 2006),
and the placement of histone modifications (Delaval et al., 2007; Lindroth et al.,
2008).  Further evidence for the importance of DNA methylation in imparting
proper imprinted expression is derived from loss-of-function Dnmt1 mutant
mouse embryos, which exhibit a disruption in normal imprinted expression
patterns at the H19, Igf2, and Igf2r loci (Li et al., 1993).
I.2.1.2 Histone modifications and RNA
Differential histone modifications are also associated with both the
expressed and silent alleles for several imprinted loci studied, though are not
as well-characterized as DNA methylation in the imprinting process.
However, there is ample evidence that epigenetic tags differ with parental
allele, and that these tags are correlated with expression pattern (Delaval et al.,
2007; Lindroth et al., 2008).  Additionally, imprinting can result from the
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production of ncRNAs that direct the silencing of a particular allele, as is the
case with the Igf2r/Air and Kcnq1/Kcnq1ot1 loci.   Both of these loci contain
ncRNA promoters within their ICRs, and methylation of the ICR prevents
transcription of the ncRNA (Wutz et al., 1997; Thakur et al.,  2004).  Thus while
the mechanisms regulating genomic imprinting in mammals are becoming
better understood, the function of imprinted expression is still a fundamental
question.
I.2.2 The Evolution of Imprinting: the conflict hypothesis
One might question the selective advantage of forgoing diploidy at an
imprinted locus: indeed, silencing one of two alleles present could be
detrimental in a case where the expressed allele contains a recessive mutation.
In this situation, despite the presence of a wild-type allele, expression will
only be derived from the mutated allele, which could lead to reduced fitness
of the organism.  Diseases associated with imprinting mutations exist in
humans and can be modeled in other organisms.  Beckwith-Wiedemann
syndrome (BWS), Prader-Willi syndrome (PWS), and Angelman Syndrome
(AS) occur when imprinted genes are improperly expressed (reviewed in
Robertson, 2005).  [Alarmingly, the incidence of imprinting-related diseases is
increasing, especially among children conceived through the use of assisted
reproductive technologies, which suggests that the processes necessary for
maintaining proper epigenetic marking may be adversely affected by early
embryo manipulations (Cox et al., 2002; Maher et al., 2003).]
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Thus one fundamental question in the study of genomic imprinting is
how imprinting evolved in mammals, despite the consequences of giving up
diploid protection against recessive mutations.
The theory explaining genomic imprinting in mammals that is best
supported by experimental evidence is known as the “conflict hypothesis” or
the “kinship hypothesis”.  Proposed by Moore and Haig in 1991 (Moore &
Haig, 1991), the conflict hypothesis suggests that imprinting results from the
differing interests of the maternal and paternal genomes with regard to
maternal resource allocation and offspring development.  In non-
monogamous species – where paternity is not a foregone conclusion – it is in
the paternal genome’s interest to maximize maternal resource distribution to
pups in one litter – the litter that is most likely sired by a given father.  Thus,
in an effort to maximize reproductive fitness, the paternal genome acts to
promote maternal resource distribution to pups of known paternity, even to
the potential detriment of both the mother and pups sired by other fathers.
The maternal genome, however, is more conservative when considering how
resources ought to be distributed and instead maximizes reproductive fitness
by more parsimoniously allocating resources, both among pups within a
single litter, across litters, and the mother herself.  It is more costly and
difficult for the maternal genome to reproduce, thus producing the most
progeny with the greatest chance of survival is a priority.
One prediction of the conflict hypothesis is therefore that paternally-
expressed genes will act to maximize the growth of offspring in such a way
that demand for maternal resources is greatest; in other words, paternally-
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expressed genes are predicted to act as growth-promoters.  On the contrary,
maternally-expressed genes are predicted to inhibit offspring growth so that
the development of future litters and the maintenance of maternal
reproductive fitness can be maximized.  Indeed, there are numerous examples
of paternally-expressed genes acting as offspring growth promoters (Snrpn,
Peg3, Peg1, Igf2, Rasgrf1) and maternally-expressed genes acting as offspring
growth inhibitors (Ube3a, Gnas, Grb10, Igf2r).  One elegant example in mouse is
the Igf2/Igf2r relationship: Igf2 is a paternally-expressed, growth promoting
gene, and loss of Igf2 expression leads to intrauterine growth retardation
(DeChiara et al., 1990).  Igf2r is materally-expressed,  acts as a growth inhibitor,
and codes for the IGF2 receptor; loss of Igf2r expression leads to fetal
overgrowth (Ludwig et al., 1996).  The mechanism whereby expression at
imprinted loci becomes preferentially monoallelic is proposed to resemble a
gradual tug-of-war between the genomes, which results ultimately in
monoallelic expression from one genome or the other as gradual increases or
decreases in expression are modulated (Wilkins & Haig, 2003).
I.2.2.1 A critical assumption
A fundamental assumption that this theory rests on is that gene
expression level is the critical piece in contention (Wilkins & Haig, 2003), and
that monoallelic expression of equivalent quantity from one genome or the
other does not produce a fundamentally different phenotype.  The conflict
hypothesis assumes that for each imprinted gene, there is a maximally
beneficial level of gene expression (for one genome or the other), and that the
evolutionary tug of war is engaged in to produce this optimum level.  In the
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case of genes that promote offspring growth, this leads to silencing of the
maternal allele in response to increased levels of expression from the paternal
allele, and vice versa in the case of genes inhibiting offspring growth.  To date,
however, while there are many instances where individual gene expression
patterns tend to support the conflict hypothesis, there has only been one study
done which tests this fundamental assumption (Drake et al., 2009).  However,
it is has been proposed that loci where recessive mutations might produce a
deleterious phenotype are the least likely to be imprinted (Ubeda & Wilkins,
2008).
I.2.2.2 Additional theories
Other theories do exist to explain the development of mammalian
imprinting, yet experimental evidence for these is not as strong.
One early theory suggested that genomic imprinting can lead to
reproductive isolation and hence evolved as a post-zygotic speciation
mechanism (Varmuza, 1991).
'Evolvability' models propose that haploidy at imprinted loci promotes
enhanced adaptability within a population by 'hiding' the silenced alleles from
natural selection (Beaudet & Jiang, 2002). In this scenario, those silent alleles
are afforded the opportunity to accumulate multiple potentially deleterious
mutations that could interact synergistically with other similar loci to produce
an adaptive phenotype; these same mutations would otherwise be eliminated
if they were immediately visible to natural selection.  Thus the evolvability
hypothesis suggests imprinting contributes to the development of a pool of
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hidden genetic variation, but does not provide an explanation for which loci
are imprinted, or which parental allele is silenced.
The 'ovarian time bomb' hypothesis (OTB) suggests that imprinting
evolved to prevent ovarian teratomas from producing invasive trophoblasts
(Varmuza & Mann, 1994), since paternally-contributed genetic material is
necessary for trophoblast development.  Thus, the genes required for
trophoblast development are predicted to be maternally-silenced and
paternally-expressed, which is the pattern observed.  However, the OTB fails
to explain why we see imprinting at loci unimportant for trophoblast
development, why imprinting persists in somatic tissues,  why some paternal
genes are silenced,  and why imprinting exists in species lacking invasive
placentas.
The 'maternal-offspring' coadaptation theory (Wolf & Hager, 2006)
suggests that imprinting increases  the adaptive integration of maternal and
offspring genomes, which leads to higher fitness for the offspring, facilitates
beneficial maternal-offspring coadaptive trait development, and explains the
relative overabundance of maternally-expressed autosomal genes (particularly
in the placenta).
Collectively, these theories fail to address various characteristics of
imprinted loci, including which parental allele is silenced, why certain loci are
imprinted,  the presence of imprinted expression in somatic tissues, and the
presence of imprinting in species lacking invasive placentas.
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I.3.  Rasgrf1
I.3.1 Imprinting
Imprinting at Rasgrf1 is controlled by the placement of methylation at a
differentially methylated domain (DMD) located 30kb upstream of the gene’s
promoter (Yoon et al., 2002; Figure I.1).  The locus contains two elements that
impart imprinted expression: the DMD, which is capable of being methylated,
and a series of repeats which immediately flank the DMD and act to direct
methylation.  On the transcribed paternal allele, the DMD is methylated; on
the silenced maternal allele, the DMD is unmethylated.
The placement of methylation is directed by a signal emanating from
the repeats;  the repeat unit consists of a 41-mer and is repeated 40 times.
Excision of the repeats (the tm1 allele; Figure I.2) leads to a failure to acquire
methylation at the DMD, which in turns leads to allele silencing.  Silencing at
the  maternal allele is due to the presence of CTCF – a methylation-sensitive
enhancer-blocking protein, which can bind the DMD in the absence of
methylation (Yoon et al., 2005).  CTCF blocks communication between a
presumed endogenous enhancer (not yet identified) and the Rasgrf1 promoter;
when the DMD is methylated, CTCF cannot bind, and the enhancer can act in
concert with the promoter to produce gene expression.  Replacement of the
repeats with the PGK enhancer (the tm2 allele; Figure I.2) leads to allele
transcription, suggesting that the placement of an enhancer between the
CTCF-bound DMD and promoter is sufficient to activate transcription.  The
mechanism whereby the maternal allele becomes active and escapes silencing
around weaning is unknown.
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FIGURE I.1: Allele-specific methylation at the DMD
governs allele-specific Rasgrf1 expression in neonatal
mouse brain.  The paternal DMD is methylated; the
maternal DMD is not.  CTCF binds to the maternal DMD
and blocks endogenous enhancer-promoter interactions,
leading to silencing of the maternal allele.
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FIGURE I.2:  Schematic of tm1 and tm2 alleles.  The
tm2 allele contains an inserted cassette in place of
the repeats and the tm1 allele contains a repeat
deletion.
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The sequence elements controlling imprinting at Rasgrf1 are absent in
humans; therefore, Rasgrf1 is presumably not imprinted.  However, Rasgrf1
expression is imprinted in other murine relatives of mice, including rats.
I.3.2 Expression & Phenotypes
Rasgrf1 is located on mouse chromosome 9 and encodes a 140kD
protein.  In mouse, Rasgrf1 is imprinted and expressed preferentially from the
paternal allele in neonatal mouse brain (Plass et al., 1996); at weaning,
expression at the locus becomes biallelic (Drake et al., 2009), with active
maternal allele transcription that persists through adulthood.  Rasgrf1 is
predominantly expressed in brain and is absent from most other somatic
tissues, with the exception of low levels of imprinted expression in heart, lung,
stomach (Plass et al., 1996; Ferrari et al., 1994; Zippel et al., 1997) and pancreas,
where the imprinting status is unknown  (Arava et al., 1999, Guerrero et al.,
1996; Font de Mora et al., 2003).  Upstream of Rasgrf1 are two ncRNAs, A19
and AK029869, that are paternally expressed but have unknown functions (de
la Puente et al., 2002; Brideau et al., in prep).  A variety of pleiotropic
phenotypic effects are associated with loss of Rasgrf1 expression, including
postnatal growth retardation, decreased levels of circulating IGF-1, impaired
performance on learning and memory tasks, and electrophysiological
differences in neuronal signaling (Itier et al., 1998; Brambilla et al., 1997; Giese
et al., 2001; Tonini et al., 2001; Clapcott et al., 2003; Font de Mora et al., 2003;
Drake et al., 2009).
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I.3.3 Protein function and signaling
RasGRF1 acts as a guanine nucleotide exchange factor (GEF) for the
small G-proteins Ras and Rac (Cen et al., 1993; Innocenti et al., 1999; Kiyono et
al., 2000) by catalyzing the exchange of inactive, bound GDP for activating
GTP.  GTPase activating proteins (GAPs) catalyze the opposing reaction,
where GTP is exchanged for GDP (Boguski & McCormick, 1993).  The
RasGRF1 protein contains a catalytic CDC25 domain at the C-terminal of the
protein, Dbl- and pleckstrin-homology (DH/PH) domains at the N-terminal,
and REM and IQ regions more centrally (Figure I.3).
The CDC25 portion of the protein is responsible for activation and
signaling through Ras pathways, and it can act as an exchange factor for H-
Ras, K-Ras, N-Ras, and R-Ras (Gotoh et al., 1997; Tian & Feig, 2001).  The
DH/PH tandem domain is responsible for activation and signaling through
Rac pathways (Yang & Mattingly, 2006).  Activation of the RasGRF1 protein
itself occurs principally in response to calcium influx or serine
phosphorylation.  Multiple serine residues are phosphorylated in a PKA-
dependent manner (Mattingly et al., 1999; Yang et al., 2003), while the REM
domain is responsible for autophosphorylation.  Calcium signals are sensed
through the IQ domain (Farnsworth et al., 1995), though intact PH and coiled-
coil domains are necessary for efficient calcium-sensitive regulation
PH DH PH                CDC25
FIGURE I.3:  Structure of RasGRF1 protein indicating relative placement of
pleckstrin-homology (PH), Dbl-homology (DH), ilimaquinone (IQ), REM, and
CDC25 regions.
 IQ domain
REM
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(Buchsbaum et al., 1996). RasGRF1 itself localizes to the plasma membrane as
well as the endoplasmic reticulum, where it activates H-Ras in a calcium-
sensitive manner (Arozarena et al., 2004).
RasGRF1 responds to several upstream signaling inputs: neurotrophin
binding to TrkA, B, and C receptors (Macdonald et al., 1999; Robinson et al.,
2005), lysophosphatidic acid  (LPA; Mattingly et al., 1999; Zippel et al., 1996 &
2000), heterotrimeric G-protein subunit dissociation (Shou et al., 1995; Kiyono
et al., 1999), and muscarinic receptors  (Mattingly & Macara, 1996).
Downstream signaling effectors are linked to Ras and Rac signaling, and
include the Rac/p38 (Baldassa et al., 2007),  P13K/Akt (Yang & Mattingly,
2006) and Ras/ERK (Farnsworth et al., 1995; Tian et al., 2004; Tian & Feig,
2006) pathways.  RasGRF1 has been shown to directly associate with the NR2B
subunit of NMDA-type glutamate receptors (Krapvinsky et al., 2003), which
couples NMDA activity to downstream ERK pathways, the GluR1 subunit of
the AMPA receptor (Tian & Feig, 2006), microtubules (Forlani et al., 2006), as
well as RNA (Lavagni et al., 2009)
I.3.4 Rasgrf1 and Rasgrf2
Rasgrf1 shares a high degree of sequence and peptide similarity with
Rasgrf2, and non-imprinted gene located on mouse chromosome 13 that codes
for a 135kD protein (Fam et al., 1997).    Similarities at the peptide level range
are between 50% and 88% for each of the protein motifs, with the main
distinctive difference between the proteins being an additional 57 amino acids
located N-terminal to the CDC25 domain in RasGRF1.  Similarly to Rasgrf1,
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Rasgrf2 expression is enriched in neurons in the central nervous system,
though with a different distribution of expression within in the brain (Allen
Brain Atlas).  Loss of Rasgrf2 appears to be dispensible for normal growth and
maturation in mice, as Rasgrf2 -/- mice displayed no differences in
development, growth, or fertility when compared to wild-type littermates
(Fernandez-Medarde et al., 2002).  However, both proteins act in concert with
the same small G-proteins and associated signaling cascades  (Fan et al., 1998),
which complicates analysis in the absence of an appropriately-specific method
of separating inputs from the two proteins.  A commercially-available
antibody that can reliably detect Rasgrf1 in the absence of any cross-reaction
with Rasgrf2 is unavailable (see Appendix); this makes the identification of
unique interactors via pull-down assay difficult, as well as complicates any
protein-based immunohistochemical imaging.
Previous work in mouse has demonstrated that Rasgrf1 and Rasgrf2
mediate opposing forms of synaptic plasticity by influencing different
hippocampal electrophysiological processes (Li et al., 2006).  In adult
hippocampal neurons, RasGRF1 associates with NR2B-containing NMDA
receptors and promotes long-term synaptic depression (LTD) by signaling
through Rac/p38 pathways.  Conversely, RasGRF2 associates with NR2A-
containing NMDA receptors and promotes long-term potentiation (LTP) by
signaling through Ras/MAPK pathways.  Additionally, the degree to which
either protein is active in neuronal processes is developmentally-regulated:
both RasGRF1 and RasGRF2 become functional in NMDA-induced Ras/Erk
signaling in more mature mice (post-natal  day 20; Tian et al. 2004), a pattern
which is seen for AMPA-induced Ras/ERK signaling as well, with activity
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commencing around post-natal day 30 (Tian & Feig, 2006).  However, both of
these latter two studies employed whole-brain protein preparations that may
have diluted the effect of Rasgrf1 activity in a particular structure of
importance.
I.3.5 Transient perturbations in Rasgrf1 Imprinted Expression
We have generated several mutant mice using the tm1 and tm2 alleles
that perturb Rasgrf1 imprinting in neonatal mice (Yoon et al., 2005).  In
combination, these engineered alleles produce four patterns of imprinted
expression that can be used to assay the effects of disrupting imprinting
during a specific developmental period (pre-weaning; Table I.1).  In the wild-
type mouse, Rasgrf1 is expressed paternally pre-weaning (termed
“monoallelic-paternal”); a paternally-inherited repeat-deletion, combined with
a wild-type maternal allele produces a mouse with no neonatal Rasgrf1
expression (+/tm1; “null”); a maternally-inherited extra-enhancer allele,
combined with a wild-type paternal allele produces a mouse with biallelic
neonatal Rasgrf1 expression (tm2/+; “biallelic”); lastly, a materally-inherited
extra-enhancer allele, combined with a paternally-inherited repeat-deleted
allele produces a mouse with materally-derived monoallelic Rasgrf1
expression (tm2/tm1; “monoallelic maternal”).  Significantly, biallelic
expression at weaning is preserved in each of these genotypes, which
recapitulates the endogenous expression pattern for the locus.
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TABLE I.1: Alleles generating different Rasgrf1 imprinted
expression patterns in neonatal mice.  All genotypes biallelically
express Rasgrf1 as adults.
  tm2
   tm2
Monoallelic paternal, MP (= wt)
Allele Neonatalexpression
♀ Ų  Ų   ♀
 +    +
   +
 +
  +
   +
   +
+
- -
-
-
 tm1
 tm1
Nomenclature
 Biallelic, B
 Null, N
 Monoallelic maternal, MM
Adult
expression
Ų♀
    +
    +
    +
    +
     +
     +
     +
     +
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These alleles are unique in that they facilitate a study of how traits
responsive to imprinted Rasgrf1 expression are affected not only by a transient
loss of Rasgrf1 expression, but also by expression from the opposite parental
allele, as well as overexpression (from the endogenous locus).  The tm2/tm1
genotype represents an inversion of imprinting such that expression is still
monoallelic, but derived from the opposite parental genome, which facilitates
the testing of parental genome-dependent phenotypes, the key untested
assumption that the 'conflict hypothesis' uses as a foundation.  Additionally,
these alleles allow us to ascribe responsibility for certain traits to expression
differences that only exist pre-weaning, when Rasgrf1 is imprinted, as
expression still becomes biallelic around weaning.  Prior published work has
made use of permanently-inactivated null alleles, where loss of Rasgrf1
expression is maintained through adulthood, thus the phenotypes assayed in
adults cannot be ascribed to the activity of the locus during the developmental
state in which expression is imprinted.
I.4. Phenotypic consequences of aberrant Rasgrf1 expression
I.4.1 Learning and Memory
Rasgrf1 is highly and preferentially expressed in neurons, where it is
located at synaptic junctions (Zippel et al., 1997; Sturani et al., 1997).  This
expression pattern led to the hypothesis that Rasgrf1 played a role in learning
and memory processes, and indeed a number of studies have demonstrated
the involvement of Rasgrf1 in synaptic communication,  electrophysiological
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parameters associated with neuronal signaling, and behaviors assayed in
mouse (Brambilla et al., 1997; Tonini et al., 2001; Giese et al., 2001; Tian et al.,
2004; Li et al., 2006;  Tian & Feig, 2006; Fernandez-Medarde et al., 2007).
Additionally, through its association with both neurotrophins and Rac
signaling, Rasgrf1 is involved in neuronal remodeling and the formation of
synapses as it contributes to the process of neurite outgrowth and extension
(Macdonald et al., 1999; Robinson et al., 2005; Yang & Mattingly, 2006; Baldassa
et al., 2007), suggesting that Rasgrf1 is an important player both in maintaining
proper synaptic communication, as well as regulating neuronal remodeling
that occurs during development and upon learning.
I.4.1.1 Behavioral Analysis
Studies of the effects of Rasgrf1 deletion on learning and memory have
made use of permanently null Rasgrf1 alleles, and tested for learning and
memory changes in adult animals using well-established behavioral
paradigms.  The first study published determined that Rasgrf1 -/- mice display
abnormal electrophysiological  measurements in the amygdala, as well as
impaired performance on a variety of amygdala-dependent  tasks, including
cued and contextual fear conditioning, and (tone/shock) active and
(light/dark) passive avoidance (Brambilla et al., 1997).  Performance on
hippocampal-dependent spatial-learning tasks (Morris water maze, radial
arms maze) was not different from wild-type performance, indicating that
Rasgrf1 plays a role in amygdala-dependent memory consolidation, and not
short-term memory or 'learning'.
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However, a second behavioral study using adult Rasgrf1-/- mice
produced contradictory results  (Giese et al., 2001).  Performance on amygdala-
dependent tasks (light/dark inhibitory avoidance and tone/shock contextual
conditioning) appeared to be normal, with the behavioral effects of Rasgrf1
deletion manifesting as impairment on hippocampal-dependent tasks
(contextual discrimination, social transmission of food preference, hidden-
platform Morris water maze).  These studies disagree over whether loss of
Rasgrf1 expression primarily affects the amygdala or the hippocampus, but
there were variations in behavioral paradigms as well as the Rasgrf1 deletion.
However, the conclusion that Rasgrf1 plays a role in learning and memory is
still valid.
I.4.1.2 Cellular Analysis
On a cellular level, Rasgrf1 deletion appears to affect the processes
known as long-term potentiation (LTP) and long-term depression (LTD;
Brambilla et al., 1997; Li et al., 2006), both of which are essential for the proper
synaptic remodeling that occurs with learning experiences.  LTP is thought to
be one the cellular processes underlying learning and memory, and it is
manifested as the strengthening of a synaptic connection in response to
simultaneous stimulation of both the pre- and post-synaptic neurons.  Gene
transcription and expression in the neuronal nucleus are necessary for the
remodeling of synapses that occurs with LTP.  Mice with Rasgrf1 deletions
display abnormal amygdalar LTP (Brambilla et al., 1997).  However, mice with
Rasgrf1 deletions also display abnormal long-term depression (Li et al., 2006).
LTD is an activity-dependent reduction in synaptic strength – distinct from
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synaptic weakening – and is also thought to be a significant cellular
contributor to synaptic plasticity and learning.  Additionally, these mice
display difficulties in activating the Ras/MAPK/CREB pathway in response
to activation of NMDA and AMPA receptors, which is important for
activating gene transcriptional events in response to learning stimuli, a
requirement for protein synthesis-dependent neuronal remodeling.
Somewhat contradictory is the observation that Rasgrf1 null mice display an
increase in hippocampal neuronal excitability, as well as an increased
susceptibility to drug-induced seizures (Tonini et al., 2001).  However,
hyperexcitability may have effects that are as detrimental to ionic
conductances and synaptic transmission  as hypoexcitability.
All of the studies assessing the effects of Rasgrf1 deficiency on neuronal
function – at both cellular and behavioral levels – have used a completely null
Rasgrf1 allele and adult animals to draw conclusions.  Therefore, while the
results of these studies certainly point to a role for Rasgrf1 in processes
involved in learning, memory, and behavior, they do not identify what the
function of imprinted  Rasgrf1 expression early in life is.
I.4.2 Rasgrf1, Growth, and Body Weight
Rasgrf1 was the first imprinted gene identified to play a role in
postnatal growth (Itier et al., 1998).  The “conflict hypothesis” necessarily
predicts that imprinted genes will be important for growth, yet prior to
Rasgrf1 being shown to produce a postnatal phenotype, only prenatal growth
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had been identified as being affected by imprinted loci (Igf2 and Igf2r, for
example; DeChiara et al., 1990; Ludwig et al., 1996).
Similar to the Rasgrf1 knockout alleles generated for the study of
learning and memory, those used to assess the role of Rasgrf1 in growth are
also permanently inactivating null mutations (Itier et al. 1998, Giese et al., 2001,
Clapcott et al., 2003, Font de Mora et al. 2003).  Therefore, while the
contribution of Rasgrf1 expression to growth is clearly demonstrated, the
importance of imprinted expression in early life can only be inferred from the
data and has not been previously directly demonstrated, nor has the result of
Rasgrf1 overexpression been tested.
Animals null for Rasgrf1 display a 15-30% reduction in size relative to
age-matched wild-type animals, and this difference is apparent shortly after
birth (Itier et al., 1998; Clapcott et al., 2003; Font de Mora et al., 2003).
Variations in the magnitude of the reduction are produced by differing strain
backgrounds and type of mutation, as Rasgrf1 null alleles used in these studies
were generated either via ENU mutagenesis (Clapcott et al., 2003) or by
targeted deletion of exons (Giese et al., 2001).  Significantly, only heterozygous
animals inheriting a paternal null allele (+/-) exhibit a reduction in growth
(Clapcott et al., 2003).  Maternal inheritance of a null allele (-/+) produces no
phenotype.  These patterns suggest that neonatal Rasgrf1 expression plays a
role of paramount importance in the determination of adult body size, and
that Rasgrf1 expression post-weaning is largely irrelevant for this phenotype.
If adult expression were important, then one might predict to see an
attenuation in size differences in (+/-) animals once maternal allele expression
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commenced at weaning; this is not observed.  Additionally, in (-/+) animals,
one might expect to see a difference in size appear at weaning due to the
absence of normal maternal allele expression; this pattern is also not observed.
Therefore, one can infer that neonatal Rasgrf1 expression plays the most
significant role in the production of normal body weight; however, from these
results it is unclear whether the level of neonatal Rasgrf1 expression is
important, or whether the parent from whom expression is derived is
significant.
The link between neuronal Rasgrf1 expression and growth is likely to be
indirect; several candidate downstream effectors have been identified, though
no previous work has elucidated a clear connection between Rasgrf1 and any
of them.  Rasgrf1 null mice display decreased  levels of circulating IGF-1, and
reduced pituitary growth hormone levels (Itier et al., 1998), decreased  levels
of circulating insulin and IGF1, and increased rates of lipid catabolism (Font
de Mora et al., 2003).  However, differences in growth appear not to result
from differences in metabolism but rather from a change in overall growth
regulation processes.
I.4.2.1 The growth hormone/IGF-1 (GH/IGF-1) axis
The growth hormone/IGF-1 (GH/IGF-1) axis is a major regulator of
postnatal overall body growth and development, with effects on every major
body tissue and organ (Lupu et al., 2001).  The contribution of IGF-1 to
postnatal growth and development begin immediately after birth, whereas the
effects of growth hormone-dependent processes appear shortly after weaning
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(Meyer et al., 2004).  Because differences in body size observed between
Rasgrf1 null and wild-type mice are apparent before weaning (Drake et al.,
2009), IGF-1 and its interactors appear to be likely candidates for involvement
in the link between between Rasgrf1 and growth.
I.4.2.1.1 Igf1
IGF-1 (also known as somatomedin c) is a 7.6kD protein that exists in
two isoforms that use of two different promoters within the Igf1 genomic
sequence.   Additional sequence variants are produced by alternative splicing
at the 3’ end of the transcript as well.  Isoform 1 is transcribed from the
promoter most 5’ of the entire coding region; during splicing, exon 2 is
removed.  Isoform 2 transcription begins 5’ of exon 2, leading to the omission
of exon 1 from the transcript.  At the 3’ portion of the transcript, exon 5 is
variably included or excluded, producing transcripts with either 4 or 5 exons
(Dobrowolny et al., 2005).  However, despite the complexities of Igf1 at the
transcript level, both isoforms contain the same insulin-like peptide regions
that confer functionality for the mature protein; there are differences in
isoform distribution both with age and tissue type.  Igf1 transcription is
initiated with the participation of transcription factors including Stat5b (Hosui
& Hennighausen, 2008).  The signals leading to activation of this pathway are
well-studied in relation to the production of isoform 2 in the liver, but are less
well-understood in systems leading to isoform 1 transcription in target tissues.
IGF-1 is primarily released from the liver in response to growth
hormone signals derived from the pituitary, and isoform 2 predominates in
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circulation, where it is complexed with a number of IGF binding proteins
(IGFBPs) and the acid-labile subunit (ALS) which act to both prolong the
protein’s half-life and sequester it, rendering it inactive.  From the liver, IGF-1
is secreted and can travel to target tissues, bind to the IGF-1 receptor, and
stimulate signal transduction cascades involving such downstream effectors
as PI3K and Akt, both of which promote cell division.  In addition to liver-
derived IGF-1, IGF-1 isoform 1 produced within the target tissues themselves.
This locally-produced isoform acts to promote growth in an autocrine manner,
though its contributions to overall growth and development are less
significant than those of the circulating form.  However, there is emerging
evidence indicating that locally-derived IGF1 may play a more important role
in growth than initially thought, as increased levels of isoform 1 can rescue
some of the phenotype produced by the loss of liver-derived IGF1 (Yakar et al.,
1999).
I.4.2.2 Regulation of the GH/IGF-1 axis
The GH/IGF-1 axis is neuronally-regulated and properly maintained
through the existence of feedback loops.  Though IGF-1 is ultimately released
from the liver and can serve as an indicator for proper axis function, the
upstream components of the axis originate within the ventromedial
hypothalamus.  The hypothalamus is a structure located at the base of the
brain that integrates signals and plays a role in a number of homeostatic
processes including regulation of appetite and feeding behavior, hormonal
signaling, body temperature, and circadian rhythms.  Growth hormone
releasing hormone (GHRH) is produced in the arcuate nucleus of the
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ventromedial hypothalamus and travels to the pituitary through the
hypophyseal portal – a structure comprised of both neurons and blood
vessels.  In the pituitary, GHRH signals via its receptor (GHRH-R) to promote
the synthesis and release of growth hormone (GH), which is secreted and
signals via its receptor (GH-R) in the liver to promote IGF-1 secretion (Figure
I.4).  From there, IGF-1 is released into circulation and reaches target tissues
(bone, muscle, organs) where it signals via its receptor (IGF1-R) and stimulates
a number of processes including bone growth and elongation, muscle cell
development, and organogenesis.  Feedback loops maintain the proper level
of IGF-1 in circulation by affecting the level of GHRH in the hypothalamus, as
well as the level of somatostatin, a peptide which acts to inhibit signaling
through the axis and reduce the amount of IGF-1 in circulation.
Transcription factors known to play a role in regulating the major
players in this axis are beginning to be understood, though the complexity of
the axis necessarily creates difficulties in identifying the network of
interactions.
As mentioned previously, the GH/IGF-1 axis plays a major role in
postnatal growth, with IGF-1 levels increasing from birth onward, though the
relative amounts of each isoform vary with age, with isoform 2 becoming
more abundant with maturation.  IGF-1 and IGF1-1 receptor knockout mice
display growth retardation immediately upon birth, and complete knockouts
exhibit a host of other phenotypes including respiratory distress and a high
percentage of postnatal lethality (Liu et al., 1993, 1998).  Heterozygotes display
an intermediate reduction in size.  GH and GH-receptor knockout mice are
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FIGURE I.4:  Schematic of the growth hormone/IGF-1 axis.  Structures are
indicated on the right, and axis components are circled.
GHRH/somatostatin
GH
Igf-1
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pituitary
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normally-sized at birth but display significant size deficits commencing
around weaning (Zhou et al., 1997; Meyer et al., 2004).  GHRH knock out mice
are reduced in size shortly after birth, have lower levels of IGF-1 in circulation,
and decreased amounts of pituitary growth hormone (Alba & Salvatori, 2004).
Overexpression of pathway components leads to modest increases in size,
though not of the magnitude one might expect, perhaps due to the presence of
well-developed feedback loops.
I.5  Present studies
I intend in this dissertation to present work furthering the
understanding of the role imprinted Rasgrf1  expression plays in the
presentation of growth and learning phenotypes in mouse.  These two
principal phenotypes will be elaborated upon, with identification of pathways
linking each phenotype to imprinted Rasgrf1 expression.  I make use of the
transient imprinting mutants to help establish whether each phenotype is
dependent upon proper imprinting in neonatal mice, as the importance of
genomic imprinting in producing a number of phenotypes is just beginning to
be understood.
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II.  IMPRINT SWITCH MUTATIONS AT RASGRF1 SUPPORT CONFLICT
HYPOTHESIS OF IMPRINTING AND DEFINE A GROWTH CONTROL
MECHANISM UPSTREAM OF IGF11
II.1 Abstract
Rasgrf1 is imprinted and expressed preferentially from the paternal
allele in neonatal mouse brain.  At weaning, expression becomes biallelic.
Using a mouse model, we assayed the effects of perturbing imprinted Rasgrf1
expression in mice with the following imprinted expression patterns:
monoallelic-paternal (wild-type), monoallelic maternal (maternal-only),
biallelic (both alleles transcribed), and null (neither allele transcribed).  All
genotypes exhibit biallelic expression around weaning.  Consequences of this
transient imprinting perturbation are manifested as overall size differences
that correspond to the amount of neonatal Rasgrf1 and are persistent,
extending into adulthood.  Biallelic mice are the largest and overexpress
Rasgrf1 relative to wild-type mice, null mice are the smallest and underexpress
Rasgrf1 as neonates, and the two monoallelically-expressing genotypes are
intermediate and indistinguishable from one another, both in size and in
Rasgrf1 expression level.  Importantly, these data support one of the key
underlying assumptions of the "conflict hypothesis” which describes the
evolution of genomic imprinting in mammals, and supposes that equivalent
amounts of imprinted gene expression produce equivalent phenotypes,
regardless of which parental allele is transcribed.  Concordant with the
                                                 
1 Drake NM, Park YJ, Shirali AS, Cleland TA and Soloway PD (2009) Imprint switch mutations at
Rasgrf1 support conflict hypothesis of imprinting and define a growth control mechanism upstream of
IGF1.  Mammalian Genome, epub ahead of print, 10 June 2009; doi:10.1007/s00335-009-9192-7
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difference in overall body size, we identify differences in IGF-1 levels, both in
serum protein and as liver transcript, and identify additional differential
expression of components upstream of IGF-1 release in the GH/IGF-1 axis.
These data suggest that imprinted Rasgrf1 expression affects GH/IGF-1 axis
function, and that the consequences of Rasgrf1 inputs to this axis persist
beyond the time period when expression is restricted via epigenetic
mechanisms, suggesting that proper neonatal Rasgrf1 expression levels are
critical for development.
II.2  Introduction
Imprinted genes are expressed preferentially from one of two parental
alleles in a predetermined manner.  Epigenetic mechanisms distinguish the
two alleles from one another and control imprinted expression, which can be
tissue-specific or restricted to certain developmental stages.  Imprinted genes
have been identified in a variety of eutherian and meta-eutherian mammals
(Wiedman et al.,2004; Suzuki et al.,2005; Edwards et al., 2007), suggesting that
imprinted loci have somehow escaped the protection diploid expression
provides against recessive mutations, though the possibility exists that
imprinting might evolve at loci where deleterious mutations are the least
likely to be recessive (Ubeda & Wilkins, 2008).
A widely-accepted theory explaining the emergence of genomic
imprinting in mammals is the “conflict” or “kinship” hypothesis (Moore &
Haig, 1991).  It postulates that conflict exists between parental genomes
regarding the transfer of maternal resources to offspring, with paternal
reproduction benefiting from abundant transfer and maternal reproduction
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benefiting from parsimonious transfer.  At loci that control this transfer, the
gradual tug-of-war between the genomes over optimum expression levels
ultimately results in imprinted monoallelic expression.  Maternally-expressed
imprinted genes are predicted to act as growth inhibitors in offspring, and
paternally-expressed imprinted genes are predicted to act as growth
promoters.
Rasgrf1 is an imprinted gene that is expressed preferentially from the
paternal allele in neonatal mouse brain, with maternal allele expression
identified in adults (Plass et al., 1996); expression is high in the central nervous
system, though low levels of expression have been identified in other tissues
(Plass et al., 1996).  RasGRF1 is a 140kDa protein that acts as a guanine-
nucleotide exchange factor and activates the small g-proteins Ras and Rac
(Innocenti et al., 1999; Yang & Mattingly, 2006) in a calcium-dependent
manner (Farnsworth et al., 1995).  As its expression pattern might suggest,
Rasgrf1 plays a role in learning and memory (Brambilla et al., 1997; Giese et al.,
2001) and associates with NMDA and AMPA receptors in neurons
(Krapivinsky et al., 2003; Tian et al., 2004; Tian & Feig, 2006).
As predicted by the conflict hypothesis, Rasgrf1 is also known to play a
role in postnatal growth.  Mice completely lacking Rasgrf1 expression display
a moderate 15-30% reduction in weight that varies depending on the mouse
strain, type of mutation introduced, sex and age assayed (Itier et al., 1998;
Giese et al., 2001; Clapcott et al., 2003).
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Studies completed previously have all used permanent Rasgrf1 null
alleles; thus, none have considered the consequences of transiently perturbing
Rasgrf1 expression during the neonatal period, which is when Rasgrf1
expression is imprinted.  Using two mouse models previously described
(Yoon et al., 2002; Yoon et al., 2005), in which Rasgrf1 imprinted expression is
disrupted, we have assayed the importance of proper neonatal imprinted
expression.  Additionally, combining these models produces an imprinting
switch, in which expression is maternally-derived with corresponding
paternal allele silencing.  This unique feature allowed us to test the
equivalence of expression derived from either parental allele; more
specifically, we could ask whether equivalent phenotypes arise when
equivalent amounts of expression are maternally or paternally contributed,
which is a critical assumption that the conflict hypothesis rests on (Wilkins &
Haig, 2003).  The hypothesis assumes that genomic imprinting in mammals
emerged solely as a means of controlling the levels of total imprinted gene
expression, and that there are no qualitative differences between expression
derived from the two parental alleles.  Our series of mutant alleles at the
Rasgrf1 imprinted locus afforded us the opportunity to test whether this
assumption is valid, in addition to asking whether neonatal misimprinting has
phenotypic consequences.
Two mutated Rasgrf1 alleles – termed tm1 and tm2 – transiently impart
three additional patterns of imprinted expression in neonates (Yoon et al.,
2002; Yoon et al., 2005).  Imprinted expression at the Rasgrf1 locus is controlled
by methylation at a differentially methylated domain (DMD) 30kb upstream
of the gene’s promoter; the DMD is flanked 3’ by a series of repeats that direct
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the placement of methyl groups on the paternal allele DMD.  When these
repeats are deleted – as they are in the tm1 allele – the DMD fails to acquire
methylation and expression is silenced.  An unmethylated DMD is a target for
CTCF binding, which acts as an enhancer-blocker and inhibits communication
between the gene’s endogenous enhancer and its promoter.  When an extra
enhancer is inserted in place of the repeats – as is the case with the tm2 allele –
expression is present even in the absence of DMD methylation because the
extra enhancer bypasses the need for endogenous enhancer-promoter
communication.  Inheriting these two alleles in various combinations
produces four different patterns of imprinted neonatal Rasgrf1 expression:
wild-type mice (+/+) exhibit monoallelic-paternal (MP) expression, biallelic
mice (B, tm2/+) express Rasgrf1 from both alleles, null mice (N, +/tm1) do not
express Rasgrf1 from either allele, and monoallelic-maternal mice (MM,
tm2/tm1) express Rasgrf1 from the maternal allele.  The MM mice represent an
inversion of imprinting because Rasgrf1 expression is still monoallelic, but
maternally-derived.  Importantly, biallelic expression of Rasgrf1 is maintained
in adult animals from each of these genotypes, mimicking the wild-type
relaxation of imprinting at the locus.
We demonstrate here that transient perturbations in Rasgrf1 imprinted
expression significantly affect overall growth, and that the phenotypic effect of
imprinting mutations persists into adulthood, beyond the period during
which expression is epigenetically restricted.  Biallelic animals are the largest,
null animals are the smallest, and monoallelic-paternal and -maternal animals
are intermediate between the two and indistinguishable from one another.
Differences in adult size are sensitive to the overall level of neonatal Rasgrf1
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expression, not the allele from which expression is derived, which validates an
important assumption of the “conflict” or “kinship” hypothesis.  We also
demonstrate that Rasgrf1 produces this effect through involvement of the
growth hormone/IGF-1 axis, as differences in IGF-1 serum protein and liver
transcript levels exist, as well as differential expression of genes upstream of
IGF-1 release that are critical for proper functioning of this neuroendocrine
axis.
II.3  Materials & Methods
II.3.1  Breeding Scheme
Mice were generated as described previously (Yoon et al., 2002; Yoon et
al., 2005), with tm1 and tm2 alleles maintained on a C57/Bl6 background.
Mice used for initial weight measurements are littermate controls generated
by crossing tm2/+ females with +/tm1 males to facilitate maternal
transmission of the tm2 allele and paternal transmission of the tm1 allele and
produce all four genotypes in a given litter.  Weaning occurred at day 21.
Mice used for subsequent gene expression assays, body composition analyses,
and IGF-1 measurements were generated by crossing homozygous mice:
tm2/tm2 females were crossed with tm1/tm1 males and +/+ males to generate
tm2/tm1 and tm2/+ animals, respectively; +/+ females were crossed with
tm1/tm1 and +/+ males generated +/tm1 and +/+ animals, respectively.
II.3.2  Animal measurements
Weights were measured weekly.  Length measurements were taken at
the same ages using calipers, and included only the body length of the mouse.
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Organ weights (liver, spleen, kidney, thymus) were measured immediately
post-dissection and normalized to pre-dissection body weight.  Body
composition was measured via NMR and performed by the University of
Cincinnati Mouse Metabolic Phenotypic Center.  Meal sizes were assayed
using singly-housed P63 adult animals by weighing the amount of food both
before and after a 3-day period.  Animals were housed in wire-bottom cages
so that food particles could be collected from the bottoms and included in the
post-trial measurements.
II.3.3 Rasgrf1  Imprinted Expression
RNA was isolated from the brains of mice between embryonic day 13.5
(e13.5) and adulthood at postnatal day 42 (P42).  Mice arose from crosses
between 129S4Jae mothers and PWK fathers. PWK has a polymorphism in the
3’ untranslated region of the mRNA containing a HhaI site that 129S4Jae lacks,
so after RT-PCR, PCR products (F: CTTGGT GTTCATCGAGGAGG; R:
ATATTCTCGGGGAAGCACAC) can be digested with HhaI, and digestion
products will reveal which allele is expressed.  PCR products generated after
cDNA amplification were run on a gel without HhaI digestion or after cutting
with HhaI.  Just prior to digestion, the PCR products were mixed with a
control DNA fragment (MetFR).
II.3.4 RNA  Quantification
For Rasgrf1 transcript quantification, brains were collected from P11
neonates.  RNA was extracted, reverse-transcribed, and quantified in
duplicate using ABI Taqman© probes specific for Rasgrf1 and 18S rRNA, to
which Rasgrf1 expression levels were normalized.  Igf-1 liver transcript was
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quantified in triplicate at P21, using RNA extracted from whole liver.  An ABI
Taqman© probe recognizing both transcript isoforms of Igf-1 was used, again
normalized to 18S rRNA.
Quantification of Sst, Gh, Ghrh, IgfBp3, and Prl-R were performed using
a Sybr-Green based real-time assay.  Transcript levels were normalized to
Rpl32, a ribosomal subunit.  Prior to quantification, cDNAs and RNAs were
verified to be free from genomic DNA contamination and PCR products were
digested with appropriate restriction enzymes to verify identity.  Primer pairs:
Gh: (F) TCC TCA GCA GGA TTT TCA CC (R) GCA GCC CAT AGT TTT TGA
GC; Ghrh: (F) TGT GGA CAG AGG ACA AGC AG (R) ACA GAG GAC GGA
AAA GGT CA; Igf-1 Isoform 1: (F) CCT GCG CAA TGG AAT AAA GT (R)
ATT GAG TTG GAA GGC TGC TG; IgfBP3: (F) CGC AGA GAA ATG GAG
GAC AC (R) TTG TTG GCA GTC TTT TGT GC; Prl-R: (F) ATC ATT GTG
GCC GTT CTC TC (R) CCA GCA AGT CCT CAC AGT CA;  Rpl32:  (F) CAT
GCA CAC AAG CCA TCT ACT CA (R) TGC TCA CAA TGT GTC CTC TAA
GAA C; Sst: (F) GAG GCA AGG AAG ATC CTG TC (R) ACT TGG CCA GTT
CCT GTT TC.
II.3.5 IGF-1 Protein Quantification
Serum IGF-1 protein was quantified by a double-labeled
radioimmunoassay at Vanderbilt University’s Hormone Assay Core, a Mouse
Metabolic Phenotyping Center.  Blood was extracted from P21 animals, clotted
at room temperature for 15minutes, and spun @ 3000g for 15min @4C, after
which serum was collected.
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II.3.6  Statistics
Weight data were analyzed using a repeated measures analysis of
variance (MANOVA).  Expression data were analyzed using the student’s t-
test or the nonparametric Mann-Whitney U-test, and p-values were
Bonferroni-corrected to account for multiple comparisons.
II.4  Results
II.4.1  Rasgrf1 Imprinted Expression
We first characterized the temporal component of imprinted Rasgrf1
expression, as biallelic expression in adult brain tissues was previously
identified (Plass et al., 1996).  Rasgrf1 imprinting in brain is relaxed during
development and expression becomes biallelic around the time of weaning
(Figure II.1). The transition from strongly and predominantly paternal allele
expression to biallelic expression can be seen over time.
In contrast to previous work in which expression was only identified in
postnatal tissues (Ferrari et al., 1994), we detected transcript prenatally,
as early as embryonic day 13.5.  Next, we sought to quantify Rasgrf1 levels in
neonatal brains from animals of each of the four imprinted expression patterns
(n=3 animals/genotype) using standard qPCR with an ABI Taqman© probe
specific for Rasgrf1 (Figure II.2).   Expression levels are not significantly
different between the two monoallelic genotypes in neonatal brain (p=0.30),
but are significantly increased in biallelics (p=0.029) and significantly
decreased in nulls (p=0.0024) relative to wild-type MP mice.  These data
demonstrate the equivalence of Rasgrf1 expression level in the MM and MP
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FIGURE II.1: Imprinting at Rasgrf1 is relaxed during development.
RNA was isolated from either two or three brains of mice between
embryonic day 13.5 (e13.5) and adulthood at postnatal day 42 (P42).  Mice
arose from crosses between 129S4Jae mothers and PWK fathers.  cDNA
(UC and C) or RNA (R) was amplified by PCR.  In no cases did RNA
support amplification demonstrating the RNA we isolated had no
genomic DNA contamination.  PCR products made after cDNA
amplification were run on a gel without HhaI digestion (UC) or after
cutting with HhaI (C).   The PWK PCR product has a HhaI site lacking in
the 129S4Jae product.  Therefore, the quickly-migrating band labeled PWK
in blue are diagnostic for paternal allele expression while the slowly
migrating species labeled 129 in red is diagnostic for maternal allele
expression.  The transition from strongly and predominantly paternal
allele expression to biallelic expression can be seen over time.
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FIGURE II.2: Rasgrf1 expression in imprinting mutants.  Real-time
quantification of Rasgrf1 expression in neonatal whole brain, plotted
relative to wild-type (MP) animals.  3 animals/genotype were assayed.  P-
values (t-test) are indicated. Error bars represent standard deviations.
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genotypes, as well as the relative over- and under-expression of the B and N
genotypes, respectively; they also identify the pre-weaning period as the time
during which Rasgrf1 expression is imprinted.
II.4.2  Adult Body Size Corresponds to Neonatal Rasgrf1 Expression Pattern
We observed a range of size differences among weaned mice of both
sexes that appeared to be correlated with transient perturbations in Rasgrf1
imprinted expression.  To reliably assess these differences in size, mice were
weighed weekly, between postnatal day 8 and 63, and generated using a
breeding scheme that produced all four genotypes in a single litter.  A
difference in weight was observed that is correlated with neonatal Rasgrf1
expression level (Figure II.3), with relationships among the genotypes
mirroring those identified in transcript levels.  For both sexes, trends are the
same: nulls are significantly lighter than the other genotypes from day 16
onward (P<0.0001,,MANOVA), biallelics are significantly heavier than the
other genotypes from day 16 onward (P<0.0001, MANOVA), and wild-type
MP mice are intermediate in size between the biallelics and nulls.
Furthermore, differences in weight are proportional to differences in
length (Supplementary Figure II.S1 a, b), with biallelic mice being both
heavier and longer, and null mice being both lighter and shorter, suggesting
that we are seeing an overall growth effect and not the effect of metabolic
processes affecting weight gain alone.  Further support for this conclusion is
drawn from the results of a body composition analysis (Supplementary
Figure II.S2) indicating that differences in body composition, as reported by
body fat percentage at P63, do not reflect differences in weight.  The only
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FIGURE II.3: Rasgrf1 expression level, not parent-of-origin, controls
body weight.  Male (top) and female (middle) body weights were
measured once a week, with the number of animals indicated.  Error bars
represent standard deviations.  In comparison with the MP controls
across the full time interval, null mice were significantly lighter
(P<6x10-6), Bi mice were significantly heavier (P<2x10-4), and MM were
indistinguishable from controls.  Differences between the null and
biallelically-expressing mice were highly significant (P<8x10-17).
Representative female mice at P50 (bottom) from the null and biallelic
cohorts.
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SUPPLEMENTARY FIGURE II.S1:  Differences in weight and length
are proportional.    The ratio of length(mm) to weight(g) is plotted for
both males (a) and females (b) from P8-P63, with the number of animals
indicated.  Error bars represent standard deviations.  Mice were weighed
and measured once a week.  From P36-P63, there are no differences in
the relative proportions of weight and length among genotypes in
female mice; in males, only the nulls and wild-type mice are different
(p=0.029) during this interval.  P-values were generated using a repeated
measures MANOVA.  P-values generated across the entire interval
indicate that pre-weaning proportions vary in both sexes, but with the
exception of wild-type and null males, adult proportions are
comparable.
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SUPPLEMENTARY FIGURE II.S2:  Body Fat% is not reflective of
differences in size at P63.  Body composition was assayed in P63
mice from each genotype by NMR.  Body Fat% was plotted
relative to wild-type %, with the number of animals (male,
female) indicated.  With the exception of female biallelic and null
animals (p=0.0018), there were no significant differences in body
fat % detected among genotypes of either sex at P63, when
weights were significantly different among genotypes of both
sexes.  Error bars represent standard deviations.
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difference identified in body fat % was between female biallelic and null mice
(p=0.0018).  Additionally, the ratios of various organ weights to total body
weight are similar among the four genotypes at P21 (Supplementary Figure
II.S3).
An assessment of P63 adult meal size revealed that differences in adult
body size were not proportional to the amount of food eaten by different
genotypes (Supplementary Figure II.S4).  When food intake is normalized to
body weight, null mice are eating more per gram of body weight than are
biallelic mice (p=0.0342), suggesting that the reduction in size is not due to a
failure to eat.
Overall, these results indicate that differences in adult body size are
responsive to the level of neonatal Rasgrf1 expression, which highlights the
importance of proper imprinted expression early in development.  Among
genotypes, adult body size corresponds to the amount of Rasgrf1 in neonatal
brain, with the larger, biallelic mice overexpressing Rasgrf1 and the smaller,
null mice underexpressing Rasgrf1.  The monoallelically-expressing genotypes
are indistinguishable from one another both in transcript level and body size,
and are intermediate between the two extremes, indicating that equivalent
levels of expression do produce equivalent phenotypes, as the conflict
hypothesis assumes.  Of additional importance is the observation that
differences in weight persist beyond weaning, when expression from both
Rasgrf1 alleles commences, suggesting that pre-weaning imprinted expression
functions in the setting of parameters affecting growth through adulthood by
modulating overall Rasgrf1 expression level.
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SUPPLEMENTARY FIGURE II.S3:  Organ weights at P21 do not reflect
differences in size.  Organs from P21 males of all genotypes were
dissected, and wet weights were plotted relative to total body weight
(numbers of animals per genotype are indicated).  There are no significant
differences in the ratio of liver:body weight (t-test).  The
log(kidney:bodyweight) ratios (t-test) indicated no significant differences
among genotypes as well, as did nonparametric analysis (Mann-Whitney
U-test) of thymus:body weight ratios.  Oddly, the log(spleen:bodyweight)
data indicated a significant difference between MM and MP animals
(p=0.0102), as well as MM and B animals (p=0.0192), though this
particular difference among genotypes is not seen in any other analysis.
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SUPPLEMENTARY FIGURE II.S4:  Differences in meal size do not
reflect weight differences.  Meal sizes were measured over a 3-day period
in P63 animals that had participated in the original weight study.  Intake
for both sexes, normalized to P63 body weight measured are shown.
Significant differences were seen by t-testing between mice with null
expression (N; +/tm1;) and mice with biallelic expression (Bi; tm2/+;
p=0.0342).  Numbers of animals included are indicated.
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II.4.3  IGF-1 is decreased in transient Rasgrf1 nulls, at transcript and protein
level
Given the proportional effect of Rasgrf1 expression on overall growth,
we reasoned that a master growth-regulating axis might be affected by
Rasgrf1.  We investigated whether the growth hormone/IGF-1 axis (GH/IGF-1
axis), which is known to play a significant role in regulating post-natal growth
(Lupu et al., 2001), might be a target.  Circulating growth hormone levels are
difficult to capture accurately due to the pulsatile nature of GH secretion, so
circulating IGF-1 protein is generally used as an indication for how the system
is functioning.
IGF-1 levels were evaluated both as protein and transcript.  In serum,
IGF-1 protein was measured by radioimmunoassay at postnatal day 21 in
males (Figure II.4a).  P21 animals produce data from around the time that
growth becomes GH-dependent (Meyer et al., 2004) and display significant
weight differences in both sexes.  P21 data indicate a clear deficiency in the
amount of IGF-1 circulating protein in the null mice, relative to the biallelic
mice (p=0.0012).  There is no statistically significant overabundance of IGF-1
protein in biallelic animals relative to the intermediate genotypes.  However,
the clear difference in IGF-1 levels between the largest and smallest animals
indicates that IGF-1 is critical to the overall growth phenotype produced by
Rasgrf1 imprinting perturbation.
Decreased IGF-1 serum levels in the null mice appear to be due to a
decrease in mRNA accumulation in liver.  We quantified Igf-1 expression in
the livers of P21 male animals, using a Taqman© probe that also recognized
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FIGURE II.4: IGF-1 levels are reduced in transient nulls at P21.  Rasgrf1
expression differences are accompanied by differences in IGF-1 levels.
(A) P21 IGF-1 serum levels are reduced in transient nulls.  Serum levels
were quantified by radioimmunoassay in male mice from each genotype,
with the number of animals indicated, and plotted relative to MP (wild-
type) protein levels.  Circulating IGF-1 protein is reduced in transient
nulls relative to biallelics (p=0.0012).  Error bars represent standard errors.
(B) P21 Igf-1 transcript levels are reduced in transient nulls.  Liver Igf-1
transcript was quantified in male mice from each genotype using a
Taqman© probe specific for IGF-1 and normalized to 18S rRNA, with the
number of animals indicated, and plotted relative to MP transcript levels.
Igf-1 transcript is reduced in null animals relative to biallelics (p=0.009),
monoallelic-maternals (p<0.0001), and monoallelic-paternals (p=0.0120).
Error bars represent standard errors.
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both IGF-1 isoforms (Figure II.4b).  Taqman©-based data indicate the same
trend present in serum: nulls underexpress Igf-1 in relation to the other three
genotypes (N/B p= 0.009; N/MM p<0.0001; N/MP p=0.012) yet we cannot
identify overexpression of Igf-1 in biallelic mice.
II.4.4  Rasgrf1 affects hypothalamic inputs to the GH/IGF-1 axis
Since IGF-1 levels are affected by differences in neonatal Rasgrf1
imprinted expression (N<<B, at least, and the difference is in the predicted
direction), we raised the question of how Rasgrf1 expression in the brain might
affect IGF-1 transcription and release from the liver.  One possibility is that
Rasgrf1 levels may influence the activity of downstream transcription factors
that are upstream of IGF-1 release.  Given that Rasgrf1 is expressed
preferentially in the central nervous system, and not in the liver, we began an
investigation into whether various neural components of the GH/IGF-1 axis
are differentially expressed in our mutant mice, perhaps as a consequence of
Rasgrf1 influence on transcription factor activity.  If a particular transcription
factor were a downstream target of Rasgrf1, then differences in the transcripts
dependent on that factor might indicate its identity as a target.  Reasoning that
the differences in Rasgrf1 and IGF-1 levels are most robust in our two
“extreme” genotypes, we limited this analysis to null and biallelic male
animals, and plotted transcript quantities relative to nulls.
Transcription factors chosen as targets were CREB, Ikaros, Pit-1, and
Stat5 (Figure II.5).  Transcripts sensitive to CREB activity include somatostatin
(Sst; reviewed in Montminy et al., 1996) and growth hormone releasing
hormone (Ghrh; Mutsuga et al., 2001); transcripts sensitive to Ikaros activity
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FIGURE II.5: Differential expression of GH/IGF-1 axis components in
P21 biallelic and null males.  Differential expression of GH/IGF-1 axis
components in P21 biallelic and null males.  Sybr-Green based
quantification of genes involved in GH/IGF-1 axis function,  normalized to
Rpl32 and plotted relative to expression level in nulls.  Numbers of
animals are indicated; error bars represent standard errors.  Transcription
factors responsible for each gene are indicated below.  Overexpression in
biallelics is seen for the following transcripts:  Sst (p=0.0161), GHRH
(p=0.0458), GH (p=0.0037), Prl-r (p=0.0184), and IGF-1 (p=0.001), which
was included as a control.  No significant difference was observed in
IGFBP3 level.
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include Ghrh (Ezzat et al., 2006) and growth hormone (Gh; Ezzat et al., 2005);
Pit-1 activity is required for Gh transcription as well as other pituitary-derived
hormones, prolactin and TSHß
(Scully et al., 2000); and Stat5b-dependent transcription occurs in the liver, at
the Igf1, Prl-R, and Igfbp3 (reviewed in Hosui & Henninghausen, 2008).
Significant differences were identified between the biallelic and null animals
for somatostatin (hypothalamus; p=0.0161), growth hormone releasing
hormone (hypothalamus; p=0.0458), growth hormone (pituitary; p=0.0037),
Igf-1 (liver; p=0.001), and prolactin receptor (liver; p=0.0184).  IGF1BP3 (liver)
did not demonstrate a significant difference.
The most upstream of these components in the GH/IGF-1 axis is
growth hormone releasing hormone, which is produced in the hypothalamus
and signals via its receptors in the pituitary to affect GH release (Pombo et al.,
2000).  Efficient GHRH transcription is sensitive to Ikaros (Ezzat et al., 2006),
Gsh-1, and CREB (Mutsuga et al., 2001).  Testing the hypothesis that
hypothalamic Rasgrf1 expression could be influencing Ghrh transcription and
subsequent axis functioning, we quantified the amount of Rasgrf1 present in
the hypothalamus of P21 male mice (Figure II.6).  Nulls significantly
underexpressed Rasgrf1 relative to biallelic mice (p<0.0001), monoallelic-
paternal mice (p<0.0001), and monoallelic-maternal mice P=0.0006).  This
pattern of expression follows the trends in IGF-1 levels, both at protein and
transcript level, with the nulls expressing significantly less Rasgrf1 than the
other three genotypes. The correlation between the pattern of Rasgrf1
expression in hypothalamus and circulating IGF-1 protein suggests that
GH/IGF-1 axis functioning is affected by relative amounts of Rasgrf1 at its
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FIGURE II.6:  Hypothalamic Rasgrf1 Expression at P21 reflects trends
in IGF-1 levels.  Differences in hypothalamic Rasgrf1 expression level
mirror trends in weight, IGF-1 level, and axis components.  Rasgrf1 was
quantified in P21 male hypothalamus using a Taqman© probe specific
for Rasgrf1 and normalized to 18S rRNA.  Expression is plotted relative
to wild-type animals, with the number of animals indicated; error bars
represent standard errors.  Null mice significantly underexpress Rasgrf1
relative to biallelic mice (p<0.0001), monoallelic-paternal mice
(p<0.0001), and monoallelic-maternal mice (p=0.0006).
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hypothalamic input, which ultimately affects levels of several genes regulated
by target transcription factors that can affect IGF-1 production in the liver.
Curiously, significant correlations were identified in P21 male mice between
relative Rasgrf1 expression in hippocampus (p=0.0191) and olfactory bulb
(p=7.8e-7) and relative body weight (Supplementary Figure II.S5a,b).  Rasgrf1
expression levels in hypothalamus did not significantly correlate with body
weight.
II.5 Discussion
II.5.1  Weight data
The trends in size differences demonstrate two important points: that
Rasgrf1 expression levels between birth and weaning – when Rasgrf1 shows
imprinted expression – are critical determinants of body size through
adulthood, and that equivalent phenotypes are produced when equivalent
amounts of expression are generated from either parental allele at this
imprinted locus.  That the contribution of neonatal paternal allele-derived
Rasgrf1 is necessary for normal development has been demonstrated in work
using Rasgrf1 complete null alleles, where the mutant allele is inherited either
maternally or paternally (Clapcott et al., 2003).  Maternal inheritance of a
permanently null allele produces no phenotype, suggesting that the absence of
maternal allele expression in both neonates and adults is not critical for
normal development.  Conversely, paternal inheritance of a permanently-
inactivating null mutation produces a reduction in weight similar to that
observed in our transient nulls, and suggests that normal activity of the
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SUPPLEMENTARY FIGURE II.S5:  Rasgrf1 expression level in
hippocampus and olfactory bulb are correlated with body weight in
P21 male animals.  Weight relative to MP was plotted as a function of
Rasgrf1 expression relative to MP in P21 male mice, for individual brain
structures.  Linear regression analysis revealed significant correlations
(p-values indicated) for expression in both olfactory bulb (a) and
hippocampus  (b), and associated body weight.  Correlations for
hypothalamus and pituitary were not significant.
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maternal allele in adulthood is insufficient to rescue the loss of neonatal
paternal allele expression.
Thus, we can conclude that the weight differences observed in our
animals are sensitive to the relative levels of pre-weaning Rasgrf1, which is
when imprinting occurs and expression levels appear to be critical.  It does
appear that the engineered tm2 allele produces a noticeable – but statistically
insignificant – difference in Rasgrf1 expression level, both in whole brain at
P11 and hypothalamus at P21.  Lack of statistical significance may be due to
small sample size, and if this is indeed the case, it indicates that the GH-IGF-1
axis is tolerant of small differences in Rasgrf1 expression level, such that
equivalent size and level of IGF-1 are still characteristic of the two
monoallelically-expressing genotypes.  Larger perturbations in the expression
level of Rasgrf1 produce significant differences in size and IGF-1 levels, as
evidenced by the null and biallelic animals.
Secondly, the equivalence of the monoallelic maternal and paternal
phenotypes with respect to size and growth provides novel and valuable
support for the conflict hypothesis describing the evolution of genomic
imprinting in mammals.  Because the two monoallelically-expressing
genotypes exhibited identical size phenotypes, our data validates the central
assumption underlying the conflict model, that growth-controlling functions
of an imprinted gene are dependent only on levels of expression, regardless of
the parental allele from which expression is derived.  The experimental
support for the conflict model provided by our engineered imprinting
inversion at Rasgrf1 could not emerge from studies of currently-existing loss-
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or gain-of-function mutations at other imprinted loci.  However, support for
the predictions the hypothesis affords has been derived from other
experimental systems, most notably for the reciprocally-imprinted Igf2 and
Igf2r genes, which act together in a single system to modulate expression
levels and produce offspring of optimal size for both parental genomes (Filson
et al., 1993; reviewed by Smith et al., 2006).
II.5.2  Proportional Differences in Size
Differences in size are proportional, meaning that overall size
corresponds to overall weight.  In the absence of GH/IGF-1 axis involvement,
these data suggest that we might be seeing the effects of variations in
metabolism or feeding behavior.  To rule out these possibilities, we assayed
the body composition of male and female mice from each of the four
genotypes, and found that no significant differences existed that were
consistent between the sexes.  Feeding behavior is difficult to assay accurately
in neonates, when animals are still nursing.  Because size differences still
existed in adult animals, we reasoned that feeding differences might still be
detectable in adults, however our data indicate that a difference in food intake
is not responsible for overall difference in body size.
II.5.3  GH-IGF-1 axis involvement
The trend toward reduced IGF-1 levels in the smaller, transient null
animals, and elevated IGF-1 levels in the larger biallelic animals is clear.
Serum IGF-1 and liver Igf-1 transcript quantification both reflect this
relationship.  Transcript-level analysis also identifies a significant reduction in
mRNA accumulation in transient null livers relative to the two monoallelic
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genotypes.  These data identify the GH-IGF-1 axis as an effector of
misimprinted Rasgrf1 expression on growth.
GH-IGF-1 axis components are essential for normal postnatal growth
and development.  We observed size differences as early as the second week
of life -- earlier than that observed in GH or GH-Receptor knock-out models
(Zhou et al., 1997; Meyer et al., 2004), which suggests that Rasgrf1 is affecting
the release and activity of IGF-1 at least preliminarily in a GH-independent
manner.  IGF-1 and IGF-1 receptor knock-out mice exhibit differences in size
at birth, yet their phenotypes are much more severe, with a body weight 45-
60% that of wild-type, and a host of other characteristics including infertility
and increased rates of perinatal lethality (Liu et al., 1993, 1998).  That we have
generated a transient imprinting mutant that doesn’t fully eliminate IGF-1
expression explains the less severe phenotype we observe.  GHRH knockout
mice display reductions in size detectable as early as 2 weeks after birth,
reduced IGF-1 in circulation, and reduced pituitary growth hormone levels
(Alba & Salvatori, 2004), similar to our transient null mice. We also note that
differences in pre-weaning Rasgrf1 imprinted expression levels affect growth
into adulthood, which is expected if GH-IGF-1 activity levels are established
early in development and maintained through maturation.
II.5.4  IGF-1 & Rasgrf1
No clear link has been identified between IGF-1 and Rasgrf1, to our
knowledge, though prior to this study there were suggestions that one
influences the other.  Similar to our transient null phenotype, Itier et al. (1997)
identified reduced body weights in complete Rasgrf1 null mice that were
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accompanied by a reduction in circulating IGF-1 levels (32-40% reduced) at 4
weeks of age, and a decrease in pituitary growth hormone (42-53%) at several
ages assayed.  We have identified both of these characteristics in P21 transient
nulls.  A second suggestion of a link between Igf-1 and Rasgrf1 is derived from
data gathered using pancreatic ß-cells from Rasgrf1 null animals (Font de
Mora et al., 2003).  In wild-type islets, IGF-1 stimulation activates Akt and Erk,
but it is not effective in stimulating signaling in islets derived from Rasgrf1
null animals, suggesting that IGF-1 signaling is mediated by Rasgrf1.
However, there have been no reports of Rasgrf1 association with IGF-1
receptors, and our data suggest that the directionality of the relationship
between Rasgrf1 and IGF-1 is opposite that above, with a lack of Rasgrf1
expression leading to a decrease in IGF-1, though IGF-1 signaling relies on
feedback pathways.
We have demonstrated that feedback loops appear to be intact in our
animals by the detection of somatostatin (Sst) overexpression in biallelic
hypothalamus.  Somatostatin is an inhibitor of GH release and its expression is
stimulated by proper GH/IGF-1 axis function (Muller et al., 1999).  Thus, we
would expect to see increased levels of Sst in response to increased levels of
IGF-1.
One potential pathway connecting Rasgrf1 to IGF-1 involves the Ikaros-
dependent transcription of hypothalamic GHRH.  Ikaros is an epigenetically-
regulated transcription factor originally identified to play an important role in
hematopoietic differentation, and it exists in 8 different isoforms (Molnar et al.,
1996; Molnar & Georgeopoulos, 1994).  Ikaros-deficient mice share phenotypic
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similarities with our transient null mice and with GHRH null mice, including
a pre-weaning reduction in size, reductions in circulating IGF-1, smaller
pituitary glands, and a decrease in the amount of hypothalamic GHRH (Ezzat
et al., 2006).  Importantly, heterozygote-deficient animals display a less severe
phenotype than homozygous null animals.  Thus, one possibility is that Ikaros
itself is a target for Rasgrf1 signaling and is sensitive to reductions in Rasgrf1
expression, which produces the reduction in hypothalamic GHRH in our
transient nulls.
Another potential connection between Rasgrf1 and IGF-1 is illuminated
by mice that are null for Neurofibromatosis-1 (NF1) – a Ras-GAP that
catalyzes the opposite reaction as Rasgrf1.  These mice also display a
phenotype similar to both the Ikaros-deficient mice and our transient null
mice, with reductions in body weight, reduced hypothalamic GHRH, pituitary
GH, and liver IGF-1 (Hegedus et al., 2008).  This phenotype is due to the Ras-
independent loss of intracellular cAMP levels, a known factor in pathways
leading to CREB activation, which is necessary for efficient GHRH
transcription (Mutsuga et al., 2001).  CREB is a of RasGRF1-mediated Ras
pathways, which supports the hypothesis that differences in Rasgrf1
expression may be affecting the transcription of axis components and
producing the observed reductions in somatostatin and GHRH in our
transient nulls.
That the severity of the phenotype observed here is lesser than in
previous work is explained by the transient effect on Rasgrf1 expression.  We
are working with a gentler perturbation of expression during a specific
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developmental period, which suggests again that Rasgrf1 expression pre-
weaning is critical for normal growth and development, with clear
consequences that persist through maturation.
The present study has expanded on these relationships by identifying
more specifically where in the GH/IGF-1 pathway Rasgrf1 has an input.  The
precise mechanism by which Rasgrf1 affects GHRH levels is still unclear; it
could be via an effect on Ikaros, CREB, or Gsh-1 transcription factor activity,
or an effect on neuronal connectivity between the structures responsible for
the brain-derived portion of the neuroendocrine GH/IGF-1 axis, perhaps
through Rasgrf1’s mediation of Rac signaling, which is known to play an
important role in neurite outgrowth and extension (Baldassa et al., 2007).
II.5.5  Concluding Remarks
We have demonstrated that normal growth is dependent on the
presence of Rasgrf1, and that body size is sensitive to neonatal Rasgrf1 in a
dose-dependent manner; furthermore, this sensitivity does not depend on the
transcribed parental allele, which provides valuable and novel support for the
conflict hypothesis describing genomic imprinting in mice.  We also
demonstrated that mice null for Rasgrf1 expression as neonates display a
decrease in IGF-1, both in circulating protein and in liver transcript.
Additionally, we demonstrate that the loss of Rasgrf1 affects GH/IGF-1
components in structures as upstream as the hypothalamus, where we
identify a decrease in Ghrh transcript levels.  Overall, our data indicate that
IGF-1 is a target for signaling pathways downstream of Rasgrf1, and that pre-
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weaning imprinted expression of Rasgrf1 is critical for proper sustained
growth and development.
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III.  IMPRINTED RASGRF1 EXPRESSION IN NEONATAL MICE IS
CRITICAL FOR LEARNING AND MEMORY2
III.1 Abstract
Rasgrf1 is imprinted and paternally-expressed in neonatal mouse brain;
at weaning, expression becomes biallelic.  Neonatal mice with mutations at
Rasgrf1 that confer various patterns of neonatal imprinted expression perform
differently on an associative odor learning task, with poor performance
corresponding to a loss of wild-type paternal allele expression.  When a wild-
type paternal allele is present, augmentation of Rasgrf1 by maternal allele
activation does not improve performance on the task.  Various amounts of
Rasgrf1 underexpression (25% reduction to full null) lead to an inability to
perform well.  Differences in learning and memory among the genotypes are
not present in adult mice, all of which biallelically express Rasgrf1.  We also
identify the presence of imprinted Rasgrf1 transcript in the olfactory bulbs of
neonatal mice who are otherwise null for Rasgrf1 in the rest of the brain, and
have identified alterations  in the levels of active Ras and Rac proteins in brain
structures related to olfactory associative learning.  These results indicate that
proper levels of Rasgrf1 expression are required for learning and memory in
neonatal mice, and that canonical signaling pathways are involved in such
processes.
                                                 
2 Drake NM, DeVito LM, Cleland TA, and Soloway PD.   In prep, for submission to
Genes, Brain, and Behavior.
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III.2  Introduction
Rasgrf1 is an imprinted gene that is paternally-expressed in neonatal
mouse brain; at weaning, expression becomes biallelic (Drake et al., 2009; Plass
et al., 1996).  Rasgrf1 is highly expressed in neurons in the central nervous
system (Sturani et al., 1997; Zippel et al., 1997), though not exclusively so, as
expression has been identified in other somatic tissues (Font de Mora et al.,
2003; Plass et al., 1996).   RasGRF1 acts as a guanine-nucleotide exchange factor
for Ras and Rac proteins (Cen et al., 1993; Innocenti et al., 1999) by catalyzing
the exchange of inactive, bound GDP for activating GTP, primarily in
response to cellular calcium influx (Farnsworth et al., 1995) or serine
phosphorylation (Mattingly et al., 1999; Yang et al., 2003) in pathways
downstream of muscarinic receptor activity (Mattingly & Macara, 1996),
heterotrimeric G-protein subunit dissociation (Shou et al., 1995; Kiyono et al.,
1999), and neurotrophin binding to Trk A, B, and C receptors (Macdonald et
al., 1999; Robinson et al., 2005).
Imprinting at Rasgrf1 is controlled by a binary switch consisting of a
differentially-methylated domain (DMD) and a series of repeats immediately
3’ of the DMD .  The repeats direct the placement of methylation on the
paternal DMD, which at the Rasgrf1 locus, leads to gene transcription.  The
maternal DMD is unmethylated, which results in CTCF (a methylation-
sensitive, enhancer-blocking protein) binding; CTCF inhibits gene
transcription from the maternal allele (Yoon et al., 2002; Yoon et al., 2005).  The
repeats and DMD have been manipulated to produce two engineered alleles
(termed tm1 and tm2), that in combination, can produce varying patterns of
imprinted expression in neonatal mouse brain (Yoon et al., 2002; Yoon et al.,
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2005).   In addition to the wild-type genotype (monoallelic-paternal
expression, termed “MP” or “+/+”), animals have been generated that are
biallelic as neonates (“B,” “tm2/+”), null for Rasgrf1 expression as neonates
(“N,” “+/tm1”), or reciprocally-monoallelic (monoallelic-maternal, “MM,” or
“tm2/tm1”).  Each of these genotypes exhibits proper biallelic expression
commencing around weaning, which facilitates assaying the phenotypic
consequences of Rasgrf1 imprinting perturbations specifically in neonatal
mice, as well as querying the neonatal contribution to phenotypes present in
adults (Drake et al., 2009).
Prior work has demonstrated that Rasgrf1 expression plays a role in
postnatal growth, as Rasgrf1 knock-out mice are smaller than their wild-type
littermates (Itier et al., 1998; Clapcott et al., 2003).  We have shown that proper
imprinting in neonates is critical for maintaining a wild-type growth pattern
(Drake et al., 2009), an experiment that was made possible by the use of the
tm1 and tm2 alleles.  Additionally, we demonstrated that the parent from
which Rasgrf1 expression is derived does not contribute to phenotypic
differences, a critical but previously untested assumption of the “conflict
hypothesis” which describes the evolution of genomic imprinting in mammals
(Moore & Haig, 1991; Wilkins & Haig, 2003).
Prior work has also demonstrated that Rasgrf1 plays a role in learning
and memory (Brambilla et al., 1997; Giese et al., 2001), as adult Rasgrf1 knock-
out mice perform poorly on behavioral assays relative to wild-type controls.
However, these studies employed  permanently-inactivating null alleles and
assayed adult animals, which does not address the role of neonatal imprinted
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Rasgrf1 expression in learning and memory.    Using the tm1 and tm2 alleles,
we can ask what the consequences of transiently perturbing Rasgrf1
imprinting are, during the developmental period when Rasgrf1 expression is
normally imprinted.
III. 3 Materials and Methods
III.3.1 Subjects
Mice used for neonatal behavioral work were derived from two crosses:
+/tm1 males were bred with tm2/+ females as before, which generates four
genotypes (B, MM, MP, and N) and facilitates the use of littermate controls
(Yoon et al., 2002; Yoon et al., 2005; Drake et al., 2009);  +/+ females were
crossed with tm2/+ males, which generates the +/tm2  genotype as well as
+/+ littermates to use as controls.  tm1 and tm2 alleles are maintained on a
C57BL/6 background.  Mice used for RNA quantification were derived by
crossing tm2/tm2 , tm1/tm1, and +/+ homozygotes to generate the five
genotypes (tm2/+, tm2/tm1, +/tm1, +/+, and +/tm2).
III.3.2  Behavioral Assay:  Odors, Training and Testing
III.3.2.1 Neonatal mice, learned odor preference
Odors were prepared as in Armstrong et al., 2006, with the exception
that furyl-methyl ketone (FMK) and n-hexyl acetate (HA) were used.
Odorants used for scenting and testing were diluted in mineral oil to liquid-
phase concentrations that emitted vapor-phase partial pressures of 5.0 Pa.
Behavioral assays were conducted with all mice in a given litter trained on the
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same odorant, which facilitates the use of littermate controls, and rewarded
odorants were balanced across litters to minimized the effects of any innate
preference for either odor.
Behavior testing utilized protocols established in Armstrong et al., 2006.
Neonates in a litter received foot tattoos on P2.  Beginning on P3, pups were
separated from the dam for 90 minutes, during which they were placed on a
slide warmer to help maintain body temperature.  The dam’s nipples were
scented with the rewarded odor, and she was replaced after the 2-hour
duration.  Rewarded odorants were balanced across litters, with half the litters
rewarded for FMK, and other half for HA.
This training procedure was repeated daily through P8, when testing
occurred.  To assay acquired odor preference, pups were placed in the testing
chamber 3 hours after replacement of the dam and tested for place preference
over the two testing odors, which were labeled “A” and “B” to facilitate
experimenter objectivity.  Pups were individually tested for 120 seconds, with
the total time spent over the rewarded and neutral odors tallied.  At the start
of the testing session, pups were placed with their muzzle over the midline of
the two testing compartments, and were scored as being on one side or the
other when their muzzle was completely over one compartment.  To control
for relative immobility of pups at this age, they were replaced in the center of
the testing chamber when one of the following criteria were met: a pup fell
over and was unable to right itself, it reached the wall of the testing chamber,
remained immobile with no head movements for 3 seconds, or began circling
(more than one complete circle).  Time spent over each of the two
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compartments was measured by dual stopwatches, with a count-down timer
set for the two-minute duration.
The testing chamber consisted of a 32x19 cm arena with a wire mesh
bottom (13-cm wall height) set over two 12x19x7-cm deep compartments
(Alleva & Calamandrei, 1986; Bouslama et al., 2005), one of which contained
Kimwipes saturated with 500ul of the rewarded odor, and one of which
contained Kimwipes saturated with 500ul of the neutral odor.  The two odor
compartments were separated by a 7-cm wall thickness that was centrally
located in the middle of the testing chamber.  Between pups,  placement of the
compartments was switched; additionally, the wire mesh was reoriented with
respect to room placement halfway through each litter to control for
exogenous environmental cues.  Odor compartments were cleaned with
ethanol and allowed to dry between testing sessions.
III.3.2.2  Neonatal Mice, innate odor preference
Innate odor preference testing consisted of the place-preference portion
of the learned odor preference paradigm, minus the training sessions.  P8
neonates were placed in the testing chamber with the two training odors for a
2-minute duration.  As before, dual stopwatches recorded time spent over
each of the odors, with a countdown timer measuring the 120-second time
period.   Preference for one odor or the other was indicated by the amount of
time spent over each of the odor compartments.
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III.3.2.3  Juvenile Mice, passive avoidance
Juvenile mice were trained using a passive-avoidance foot shock
paradigm, in which a shock was administered upon stepping down off a
platform in the testing chamber.  Latency to step down was measured at
30min, 24-hour, and 72-hour intervals.
III.3.2.4 Adult Mice
Adult mice were tested on a variety of parameters related to motor
skills and coordination, learning and memory, and exploratory behavior
(Thom Cleland).
III.3.3 Rasgrf1 Quantification
Rasgrf1 quantification was carried out as before (Drake et al., 2009).
Briefly, brains were collected from P8 neonates, and relevant structures
(hippocampus and olfactory bulbs) were dissected out.   RNA was extracted,
reverse-transcribed, and quantified in triplicate using an ABI Taqman© probe
specific for Rasgrf1; 18s rRNA was used as a control to which Rasgrf1 levels
were normalized.
III.3.4  Rasgrf1 Imprinted Expression
RNA was isolated from P8 neonatal brains.  Mice arose from reciprocal
crosses between C57Bl/6 and FvB/N males and females.  RNA was reverse
transcribed into cDNA, and PCR amplified with the following primers and
cycling conditions:  (F) 5’-ggctcatgatgaatgccttt-3’  (R)  5’-tacagaagcttggcgttgtg-
3’; annealing at 58C x 40 cycles.  PCR products were then digested with 10U
AciI, which recognizes a restriction site (C’CGC) in exon 14 that distinguishes
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expression derived from either of the two parental strains.  C57BL/6-derived
expression is indicated by bands of 210/146bp, and FvB/N-derived
expression is indicated by bands at 226/130bp.
III.3.5  Ras and Rac activation assays
Brains were extracted, and relevant structures (hippocampus, olfactory
bulbs, and cortex) were dissected and placed in Krebs-Ringer solution
(11.1mM glucose, 1.1mM MgCl2, 1mM Na2HPO4,  1.3mM CaCl2, 25mM
NaHCO3, 120mM NaCl, 4.7mM KCl). Protein was extracted on ice.  Extraction
buffer included 1mM sodium orthovanadate (Na2VO4), 25mM sodium
fluoride (NaF), and EDTA-free protease inhibitor tablets (Roche)  in
magnesium-containing buffer supplied by Millipore (#20-168; 125mM HEPES,
pH 7.5, 750mM NaCl, 5% Igepal CA-630, 50mM MgCl2, 5mM EDTA, and 10%
glycerol).  Extracts were affinity purified using Ras (17-218) and Rac (17-283)
activation assay kits supplied by Millipore.  Proteins were SDS-PAGE
electrophoresed, blotted, and probed using α-Ras (05-516) and α-Rac (05-389)
antibodies supplied with the kit in conjunction with goat α mouse HRP-
conjugated IgG secondary antibody from Millipore (12-349).  Blots were
visualized using Pierce SuperSignal West Dura Substrate (34075), captured
using the LAS-4000 imager’s CCD camera and chemiluminescent detection
function, and quantified using Multigauge Software.
III.3.6  Statistics
Expression, behavior, and protein data were analyzed using the
student’s t-test or the nonparametric Mann-Whitney U-test, and p-values were
Bonferroni-corrected to account for multiple comparisons.
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III.4  Results
III.4.1  Behavioral Assays
III.4.1.1  Neonates
Given that Rasgrf1 expression is imprinted only in neonatal mice, we
asked whether neonatal learning and memory might be affected by imprinting
perturbations at the locus.  To do this, we employed an associative odor-
learning paradigm suitable for use in neonates (Armstrong et al., 2006), in
which neonatal mice were trained to learn and remember an introduced
maternal odor over a five-day training period.  Neonates were tested for
learned odor preference on P8.  We studied five genotypes: biallelics (B), nulls
(N), monoallellic-paternal (MP; wt), monoallelic-maternal (MM), and a fifth
genotype with tm2-derived paternal Rasgrf1 expression (+/tm2).  This last
genotype functioned to control for any differences in expression produced by
the tm2 allele, which is the sole source of Rasgrf1 expression in the MM
neonates.
As the associative odor learning paradigm asks whether neonatal mice
can remember and distinguish between two testing odorants (n-hexyl acetate
[“HA”] and furyl methyl ketone [“FMK”]), we first assayed innate odor
preferences among the five genotypes using the place preference portion of
the learning paradigm at postnatal day 8 (Figure III.1).
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FIGURE III.1.  Innate odor preference in P8 neonates.  Neonatal mice were tested
for any innate odor preference for either HA or FMK by using the place preference
portion of the associative odor learning assay, minus the training portion.  Mice were
allowed to indicate a preference for a 120-sec duration, and times spent over each
odor are plotted.  The numbers of mice tested are indicated in parenthesis next to
genotype.  Asterisks indicate p-values <0.05.  A significant preference was detected in
the +/tm2 genotype; any significant difference in the wild-type mice disappears
when the data for that genotype (M1 and MP2) are combined.
*
 *
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Neonates were placed in the tesing chamber for a 120-second duration.
Interestingly, the only genotype consistently indicating a preference for either
of the two testing odors was the +/tm2 genotype (n=13; p=0.02).  B (n=21;
p=0.30), MM (n=19; p=0.30), and N (n=11, p=0.59) animals displayed no
preference for either odor.  The two MP cohorts (one produced from the
breeding scheme generating the B, MM, and N animals [MP1], and the other
from the breeding scheme producing the +/tm2 animals [MP2]) varied in their
preferences.  MP1 animals (n=17, p=0.0041) displayed a preference for HA;
MP2 animals (n=13; p=0.11) displayed no preference.  When the two MP
cohorts are combined, no statistically significant preference is detected (n=30;
p=0.47).
HA and FMK were selected for use in the learned odor preference
paradigm, as the four main genotypes displayed no preference for either,
including the MM animals, where Rasgrf1 expression is tm2-derived.  The
‘rewarded’ odorant was counterbalanced across litters, with half the litters
trained to recognize HA, and the other half trained to recognize FMK.
Learned odor preferences (Figure III.2) were detected in the two
genotypes with paternally-inherited wild-type alleles, the biallelics (n=59,
p=0.0073) and the wild-types (MP1: n=53, p=0.0002; MP2: n=15, p=0.0068).
There was no significant enhancement in preference among biallelic pups
relative to wild-type littermates, as differences in time spent over each odor
were statistically insignificant between genotypes (p=0.62).  Unlike the B and
MP animals, the other three genotypes did not demonstrate a similar ability to
learn and remember an introduced maternal odor, as they exhibited no
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FIGURE III.2.  Learned odor preference in P8 neonates.  Neonatal mice
were tested for for their ability to learn and remember an introduced
maternal odor.  Mice were tested for place preference over either the neutral
or rewarded odor for a 120-second duration, and times spent over each are
plotted.  The numbers of mice tested are indicated in parenthesis next to the
genotypes.  Asterisks indicate p-values <0.01.  Significant preferences for the
rewarded odor were detected only the biallelic and wild-type cohorts.
*
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preference for the rewarded odor relative to the neutral odor (MM, n=31,
p=0.41; N, n=46, p=0.1; +/tm2, n=29, p=0.11).
Learned odor preference data indicates that the tm2 allele essentially
behaves like a null allele, regardless of whether it is materally- or paternally-
inherited, as neither the MM nor the +/tm2 animals indicated a preference for
the rewarded odorant.  This pattern was expected in the null animals (due to
prior demonstrations of learning deficiencies in Rasgrf1 -/- mice), but was
surprising in the MM and +/tm2 genotypes, which were phenotypically
indistinguishable from MP animals in terms of body size and growth (Drake et
al., 2009), which is another phenotype that Rasgrf1 contributes
to.   No significant differences in weight or length were observed between
wild-type and +/tm2 males or females (data not shown), indicating that –
similarly to maternally-derived tm2 expression – paternally-derived tm2
expression is sufficient to produce a wild-type size phenotype, but insufficient
for production of wild-type learning and memory, as assayed by the olfactory
odor learning paradigm.
III.4.1.3 Juvenile mice
We assayed learning and memory in juvenile mice using a passive
avoidance foot-shock paradigm in which mice were trained on P14 to avoid
stepping off a
platform.  Latencies to step down were measured at 30min, 24-hour, and 72-
hour intervals, and no significant results were obtained (data not shown).  We
hypothesize that this could be due to the gradual acquisition of Rasgrf1
maternal-allele expression at this age.
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III.4.1.3  Adult mice
No differences in performance on any assay were identified among
adult mice.  We hypothesize that the lack of phenotype present in adult
animals is due to the fact that all genotypes biallelically express Rasgrf1, thus
any differences due to Rasgrf1 expression are ameliorated at these ages,
therefore eliminating any resulting behavioral phenotype.
II.4.2  Transcript Quantification
Given that the tm2 allele essentially functions as a null allele in the
learning and memory assay, we asked whether the level of tm2-derived
Rasgrf1 expression differed from wild-type allele expression.  Rasgrf1
transcript level was quantified in P8 neonatal olfactory bulb, hippocampus,
and whole brain for each of the five genotypes using a Taqman© probe specific
for Rasgrf1, with data normalized to 18s rRNA levels, and then further
normalized to MP Rasgrf1 expression level (Figure III.3).  For all quantification
data, statistically-significant p-values are those that are p<0.005, the value
derived by Bonferroni-correcting for 10 multiple comparisons, and n=6 for all
genotypes except for MP, where n=7.  Transcript levels in brain (Figure III.3a)
were roughly as expected ,with biallelic mice overexpressing Rasgrf1 (p=0.001)
and null mice underexpressing Rasgrf1 (p<0.001) relative to the wild-type, MP
animals.  However, the MM (p=0.0047) and +/tm2 (p=<0.001) animals were
intermediate in expression level between the MP animals and nulls, and
significantly different from MP, a result which differs from that obtained in
P11 mice (Drake et al., 2009; dissertation Chapter 2, Figure II.2), but does
correlate with the phenotypic pattern identified in the learning paradigm.
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FIGURE III.3.  Rasgrf1 transcript quantification in P8 brain regions.  Rasgrf1
transcript was quantified in brain (a), hippocampus (b), and olfactory bulb (c).
Values were then normalized to wild-type.  N=6 animals for each genotype, except
for MP (n=7).  All p-values for brain (a) are significant and <0.01.  P-values for
hippocampus (b) are significant and <0.01 unless indicated.  Olfactory bulb (OB) (c)
p-values are significant and <0.01 unless indicated.  OB produces quantification
results mirroring the phenotypic clustering of genotypes in the learning assay: the
biallelics and wild-type mice are similar, and the monoallelic-maternal, +/tm2, and
null mice are similar.  Additionally, a low but significant level of expression is
detected in the null mice in this structure.
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Additionally, in whole brain, Rasgrf1 expression level was significantly
different between the MM and +/tm2 animals.
We reasoned that while data derived from the brain as a whole may
match the phenotypic trend in learning, it may not be specific enough to
indicate which structures might be involved in producing the learning and
memory phenotype, so we
further assayed expression in the hippocampus and olfactory bulb, the two
structures most likely involved in olfactory-based learning.   
Rasgrf1 expression patterns in hippocampus (Figure III.3b) varied from
those in brain: Biallelic (p=0.0023) mice again overexpress Rasgrf1 relative to
wild-type, null mice again underexpress Rasgrf1 (p=<0.001) relative to wild-
type, +/tm2 (p=<0.001) animals are again intermediate between the wild-type
and null levels, but the monoallelic-maternal  mice (n=6, p=0.0128) are
indistinguishable from wild-type animals.  Furthermore, there is no significant
difference between the +/tm2 and MM genotypes  in this structure (p=0.0338).
With the exception of the significant difference between +/tm2 and MP
genotypes, this pattern most closely corresponds with the phenotypic trend
we see in terms of body size, where biallelic animals are the biggest, null
animals are the smallest, and the three monoallelically-expressing genotypes
are intermediate and indistinguishable from one another.
Olfactory bulb quantification (Figure III.3c) produced an unexpected
result.  First, the biallelic and wild-type animals were not significantly
different from one another at the transcript level (p=0.8515), which mirrors the
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trend in behavioral data.  Monoallelic-maternal and +/tm2 animals were
intermediate in expression level between the wild-types and the nulls, and
again there was no significant difference between those two genotypes
(p=0.26), as in hippocampus.  The nulls were again underexpressing Rasgrf1
relative to wild-type (p<0.001); however, in olfactory bulb, the ‘nulls’ were not
null.  Instead, a low but significant level of Rasgrf1 was detected,
approximately 20% that of wild-type.  Though unexpected, this quantification
result nicely mirrors the phenotypic trend identified in the learning and
memory task:  the biallelic and wild-type animals perform significantly better
than the null, monoallelic-maternal, and +/tm2 genotypes.
III.4.3  Rasgrf1 is expressed and imprinted in null olfactory bulb
PCR analysis confirms the presence of visible Rasgrf1 bands in null
olfactory bulb cDNAs (n=6) and the absence of Rasgrf1 in null brain (n=6;
Figure III.4a).  Biallelic brain (n=5) and olfactory bulb (n=6) cDNAs were run
as controls for amplification, and Rasgrf1 transcript was detected in both
tissues.  RNA alone (with no RT reaction) produced no transcript.
We next asked whether  Rasgrf1 transcript detected in olfactory bulb
was imprinted, or if imprinting mechanisms in this structure were behaving
differently than in whole brain.  Reciprocal crosses between B6 and FvB/n
animals were set up, as well as a cross between an FvB/n mother and tm1/tm1
homozygous father.  Olfactory bulbs from P8 brains derived from these
crosses were dissected, cDNAs were generated, and Rasgrf1 transcript was
assayed for parental-specific expression using an AciI restriction site allowing
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FIGURE III.4.  Rasgrf1 is expressed and imprinted in neonatal null
olfactory bulb.  Rasgrf1 trancript was amplified in null and biallelic
brains and olfactory bulb using RT-PCR (4a).  Controls with RNA only
produced no amplification, indicating that the presence of Rasgrf1 bands
in null olfactory bulb cDNAs is indicative of expression.  Imprinted
expression in olfactory bulb was established by PCR amplification and
AciI digestion of transcripts produced by reciprocally crossing B6 (B) and
FvB/n (F) parents (4b); an additional cross (FvB/n x tm1/tm1) confirmed
the presence of Rasgrf1 transcript, despite the presence of two paternal
tm1 alleles.   Digestion of amplicons produces exclusively paternal
banding patterns.  FvB/n-derived transcript yields digested band sizes of
226bp and 130bp, and B6-derived transcript yields band sizes of 210bp
and 146bp.
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distinction of transcript derived from each of the two strains.  Results
indicated that Rasgrf1 in olfactory bulb is imprinted and paternally-derived
(Figure III.4b) as in the rest of the brain, indicating that the paternal allele in
null animals somehow escapes the silencing mechanism generated by the loss
of DNA methylation at the Rasgrf1 primary DMD (Yoon et al., 2002 & 2005).
Progeny from B6 mothers and FvB/n fathers displayed 226/130bp
bands characteristic of FvB/n-derived Rasgrf1 transcript; progeny from FvB/n
mothers and B6 fathers displayed the 210/146 bands characteristic of B6-
derived Rasgrf1 transcript.  The tm1 allele was created in a 129S4Jae line, and
maintained on the B6 background; 129 and FvB/n strains share the same AciI
polymorphism, so the banding pattern following digestion does not indicate
from which parent Rasgrf1 expression in this particular cross is derived.
However, the clearly monoallelic-paternal result from the two wild-type
reciprocal crosses, combined with the fact that we do see Rasgrf1 from this
cross – where both paternal  alleles contain the repeat-deletion – suggests that
the requirement for repeat-directed DNA methylation at the Rasgrf1 DMD is
relaxed in olfactory bulb, since transcript is still produced, although at lower
levels than in wild-type mice.
III.4.4  Other Approaches
Though differences in olfactory bulb Rasgrf1 transcript level appear to
explain the discrepancies in performance on the learning and memory task,
we also considered whether tm2-derived expression varies from wild-type by
cell type or overall distribution in the brain (Yoon et al., 2005).
Immunohistochemical approaches were ultimately unsuccessful due to the
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lack of an antibody specific for RasGRF1 peptide; commercially-available
antibodies also detect RasGRF2, a closely-related peptide that is expressed in
brain (Fam et al., 1997), making identification of differences between
genotypes unreliable by this method.  Additional attempts were made to
visualize Rasgrf1 expression in brain using RNA in situ hybridization, but
probes appeared to cross-react with Rasgrf2 as well (see dissertation Appendix
V.2).
III.4.5  Signaling
RasGRF1 acts as a guanine-nucleotide exchange factor for both Ras and
Rac proteins, and we were curious to know whether the activation of either of
these proteins was influenced by mutations at Rasgrf1.  Prior work indicates
that RasGRF1 may not be an active signaling intermediate in neonatal mice
(Tian et al., 2004), but we detected differences in associative odor learning that
correspond to the amount of Rasgrf1 expressed in neonates.  Additionally,
those prior assays were completed using whole-brain protein extracts, and our
transcript quantification work indicates that there are differences in the
relative amounts of Rasgrf1 transcript that vary by structure.
We therefore attempted to identify protein activation state using
specific structures derived from P8 neonates.  Because the MP and N mice
were significantly different from one another, we used these two genotypes
for this test.  Protein extracts from brain, olfactory bulb, and hippocampus
were assayed for the presence of activated Ras and Rac proteins.  Activated
protein was affinity-purified by incubating extracts with glutathione agarose
beads to which either the c-Raf (for Ras) or PAK-1 (for Rac) protein binding
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domains were fused, which facilitates interaction with the activated forms of
the proteins.  The amount of protein pulled down via binding was then
normalized to the total amount of Ras or Rac protein in the input lanes, which
allowed us to semi-quantitatively determine whether there were differences in
the amount of activated protein between genotypes.
Blots indicated significant alterations in the amount of activated Ras
and Rac protein between the wild-type and null animals (Figure III.5).  Data
in Figure 5 are presented as the ratio of activated protein to input, normalized
to wild-type.
Cortex produced significantly higher amounts of activated Ras in the
wild-type animals, relative to the nulls (p=0.0191), and wild-type hippocampal
extracts contained a higher amount of activated Ras and Rac proteins as well
(p=0.0137, p=0.0474, respectively). Oddly, the null animals display an increase
in the amount of activated Rac in cortical extracts, relative to wild-type
animals.  Olfactory bulb extracts produced the lowest amount of activated
proteins, for both Ras and Rac, which made even semi-quantitation of null Rac
levels unreliable.  There were no significant differences in the amount of
activated Ras protein between genotypes in olfactory bulb extracts.
Taken together, these data indicate that there are significant differences
in the amount of active signaling proteins in wild-type and null brains, and
that there are structure-specific differences in relative protein activation state,
which suggests that assays measuring activity might dilute differences in
individual structures when using whole brain extracts.
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FIGURE III.5.  Semi-quantitative analysis of the relative amounts of
activated Ras (a) and Rac (b) proteins in null and wild-type brains regions
varies by structure.  The amounts of precipitated (active) protein were normalized
to the amounts of input (total) protein for each structure, and then normalized to
wild-type.  There are reduced amounts of active Ras, relative to wild-type, in null
cortex and  hippocampus; activated Rac is also reduced in null hippocampus,
relative to wild-type.  Increases in activated Rac are seen in null cortex.  n=4 for all
comparisons, and p-values are indicated.  Representative blots are shown next to
each graph.
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III.5b (Continued)
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Thus, while we have not been able to directly link the olfactory learning
phenotype with a known biochemical pathway, we can conclusively identify
Rasgrf1 expression level as being critical for the production of normal olfactory
associative learning, and can identify subtle but significant differences in small
G-protein activation that depend on the amount of Rasgrf1 expressed, but the
dependency varies with tissue type.
III.5  Discussion
III.5.1  Rasgrf1 expression-dependent phenotypes
This study demonstrates that neonatal learning and memory – as
assayed at P8 using an associative odor-learning paradigm – is critically
dependent upon proper Rasgrf1 expression levels in neonatal brain, and is the
first study to assay Rasgrf1-dependent neonatal learning and memory.  Even a
modest reduction in Rasgrf1 level in MM mice at the whole brain level (73%
that of wild-type) is enough to produce a diminished ability to learn and
remember an introduced maternal odor.  Interestingly, this same difference
between these two monoallelic genotypes is not sufficient to produce a
difference in overall growth (Drake et al., 2009; see Dissertation Chapter 2,
Figure II.3), suggesting that the mechanisms involved in learning and memory
are much more sensitive to Rasgrf1 level than those involved in growth;
however, Rasgrf1 does not appear to be a critical limiting factor, as
overexpression in biallelics does not produce a detectable enhancement in
neonatal learning.
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The results of our previous study supported a previously untested
assumption of the conflict hypothesis (Wilkins & Haig, 2004), which describes
the evolution of genomic imprinting in mammals as ultimately being a tug of
war between the two parental genomes over optimum expression level at
imprinted loci (Moore & Haig, 1991).  Previously untested was the assumption
that equivalent amounts of expression derived from either parental allele
would produce an equivalent phenotype, which we did observe with regard
to the size phenotype at the ages assayed.  Thus, that there are differences in
phenotype between the MM and MP mice in this study does not disprove
Moore & Haig’s assumption, as tm2-derived expression at P8 does not
recapitulate wild-type expression level.  The results of the current study
instead indicate that for proper learning and memory to occur at this age,
there needs to be a level of Rasgrf1 expressed exceeding that produced by the
tm2 allele, though we cannot rule out differences in cell type or neural
distribution as contributing factors .  However, the results of this study also
support Moore and Haig’s assumption because tm2-derived expression
produces the same neonatal learning phenotype, regardless of whether the
allele is maternally or paternally inherited.
III.5.2  Rasgrf1 in Olfactory Bulb
Our current results also indicate that Rasgrf1 expression in olfactory
bulb may be subject to different epigenetic regulatory mechanisms than in
other tissues.  Null animals display tm1-derived expression in olfactory bulb,
at a level 20% that of wild-type, which is in contrast to the 1-2% observed in
hippocampus and whole brain, respectively.  Expression in this structure at
this age is exclusively paternally-derived, which indicates that the tm1 repeat
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deletion is either failing to produce relevant hypomethylation, or that
transcription regulatory mechanisms controlling imprinted expression in the
olfactory bulb differ from those used in other tissues, where imprinting also
occurs.
III.5.3 Age-related phenotypes
The loss of a behavioral phenotype with age is also not surprising, as
Rasgrf1 expression gradually becomes biallelic around weaning.  As is the case
with the tm1 allele escaping identified epigenetic controls, the mechanism
whereby the maternal allele becomes actively transcribed with maturation is
also unknown.  We do observe a lack of behavioral phenotype as early as P17,
which corresponds to the gradual onset of maternal allele expression (Drake et
al., 2009), and a similar paucity of performance differences in behavioral
assays conducted using adult mice.
Our previous observations (Drake et al., 2009) suggest that the
production of the growth phenotype relies solely on neonatal differences in
Rasgrf1 level, which explains the persistence of size differences past the point
at which expression becomes biallelic.  The behavior phenotype identified in
this study is different, in that it is responsive to the accumulation of maternal
transcript around weaning, which leads to the diminishing of performance
differences among genotypes at later ages.  However,  despite these
differences – and indeed they suggest that Rasgrf1 functions in different
pathways subject to different regulatory mechanisms – there are similarities
between the two phenotypes.  The two extreme genotypes – the nulls and the
biallelics – display early phenotypic differences both in size and in neonatal
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learning.  Transient underexpression of Rasgrf1 in nulls leads to smaller
animals with an impaired ability to learn and remember an introduced
maternal odor.  Transient overexpression in biallelics produces larger animals
that are capable of learning and remembering an introduced maternal odor, at
least as well as wild-type animals, though overexpression does not produce
any enhancement in learning and memory, suggesting that Rasgrf1 is not the
rate-limiting molecule in the relevant pathway.  Additionally, overexpression
does not lead to learning and memory deficiencies, suggesting that excess
Rasgrf1 is not toxic to the organism.  Thus, transient changes in expression do
not appear to be detrimental to overall fitness in any way, as animals of all
genotypes survive to reproductive age and are capable of bearing litters.  That
one phenotype is more sensitive to overall Rasgrf1 expression level is the only
significant difference between the two presentations, in addition to the loss of
learning and memory differences that occur with aging.
III.5.4  Rasgrf1 and Odor Learning
This work also highlights a potential role for Rasgrf1 in early associative
odor learning, as reductions in Rasgrf1 expression produce an inability to
associate odor with reward.   Early olfactory associative learning involves an
NMDA-receptor dependent process (Lincoln et al., 1988; Weldon et al., 1997),
and is mediated by CREB phosphorylation (McLean et al., 1999; Raineki  et al.,
2009).  The contribution of NMDA receptors to olfactory learning appears to
be well-conserved, as similar processes are observed in Drosophila (Xia et al.,
2005) and honeybees (Si et al., 2004), in addition to rats (Tronel & Sara, 2003)
and mice (Brennan, 1994).  RasGRF1 is known to directly associate with
NMDA receptors, via the NR2B subunit (Krapivinsky et al., 2003), which is
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striking given that certain olfactory learning processes are NR2B-dependent in
particular (White & Youngentob,  2004).  Furthermore, Rasgrf1 has been shown
to transduce signals arriving at the NMDA receptor and activate the
ERK/MAPK pathway in response (Krapivinsky et al., 2003; Tian et al., 2004) ,
which lies upstream of CREB phosphorylation.   Somewhat confounding is the
observation by Tian et al. (2004) that Rasgrf1 does not play a significant role in
NMDA-mediated signaling in neonatal mice.  While we were unable to
identify a direct link between Rasgrf1 and Ras or Rac pathway activation, we
were able to demonstrate that there are differences in the amounts of activated
protein between wild-type and null animals.
Lastly, we have been able to point to a significant amount of variability
present among different subcortical structures, both at the level of Rasgrf1
expressed, and in the amount of activated protein.  Though not surprising,
this trend indicates that important data might be missed by simply assaying
whole brain preparations instead of individual structures.  For example, one
possibility explaining the absence of an identifiable Rasgrf1 contribution to
neonatal NMDA signaling (Tian et al., 2004) is that the use of cortical slices
diluted out any relevant Rasgrf1 contribution within specific structures.
Taken together, these results indicate that proper Rasgrf1 expression is
critical for neonatal performance on an associative odor-learning task and that
mechanisms governing Rasgrf1 expression and its effects on protein activation
vary by tissue type.  We also again observe the presence of a similar
phenotype, regardless of whether Rasgrf1 expression is maternally or
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paternally derived, as evidenced by the similarities between the monoallelic
maternal and +/tm2 animals.
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IV.  EXPANDED DISCUSSION
The experiments detailed in these pages define a role for Rasgrf1 in the
presentation of two phenotypes: the first is related to growth and body size,
and the second to learning and memory.  That Rasgrf1 expression plays a part
in both of these systems is unsurprising, given established theory and
literature – but the nature of its effect on these phenotypes and the inferences
we can make about genomic imprinting are novel, due to the use of the tm1
and tm2 alleles.  These alleles are unique in that they allowed us to examine
the effects of Rasgrf1 transcript derived monoallelically from either of the
parental alleles, which has not been done before.  We could compare
monoallelic-maternal Rasgrf1 expression with monoallelic-paternal Rasgrf1
expression, which allowed us to examine whether the parental origin of the
transcript is significant in the production of phenotypes.  Additionally, the
tm1 and tm2 alleles enabled us to ask what the effects of transient
perturbations in imprinted Rasgrf1 expression were, as expression becomes
biallelic around weaning in genotypes produced by these alleles, which
recapitulates the wild-type relaxation of Rasgrf1 imprinting.  This is important
because we were able to determine whether imprinting during a specific
period in development is critical for proper phenotype presentation, instead of
asking more generally whether a permanent alteration in Rasgrf1 expression
produces a phenotype.
We first defined a role for Rasgrf1 in the production of a size
phenotype.  Overall growth and body size – as animals were not only different
in terms of body weight, but also body length – corresponded very closely to
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the overall level of Rasgrf1 expression measured in brain structures at P11 and
at weaning.  Biallelic mice overexpressing Rasgrf1 transcript were larger, nulls
were smaller, and the two monallelically-expressing genotypes – the MM and
MP cohorts – were intermediate and indistinguishable from one another.
These differences in size persisted past the point at which Rasgrf1 expression
becomes biallelic (weaning), and the phenotypic pattern suggested something
to us that no prior published studies could have observed: not only does
Rasgrf1 appear to play a critical role in the early establishment of growth
parameters, but more generally, imprinted expression at this locus appears to
be the result of parental ‘argument’ over optimum expression level.  Different
levels of expression produce different phenotypes – but when the same
amount of gene expression is derived either from the maternal or the paternal
allele, no phenotypic difference presents.  Neither of these observations could
have been made previously because earlier studies of Rasgrf1 function
employed permanent null alleles, and such alleles are insufficient to delineate
the effects of Rasgrf1 in early and later life; additionally, our system of mutant
alleles facilitated the production of the ‘reciprocal’ monoallelic genotype, a key
component in determining whether expression from the two parental alleles
produced phenotypic differences.
Our data suggest that the role Rasgrf1 plays in the setting of a metabolic
program occurs early in life (pre-weaning, with size differences observed as
early as P8) and affects the function of the growth hormone/IGF-1 axis.
Rasgrf1 knockout mice have previously been observed to display deficiencies
in various axis components, but our work is the first study to clearly identify
where in the axis Rasgrf1 has an input.  We have measured differences in
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GHRH levels, an axis component as far upstream from IGF-1 release as the
hypothalamus – which clearly links the predominantly neuronal pattern of
Rasgrf1 expression with the further downstream systemic effects on axis
function, namely the differences in circulating IGF-1 that are likely responsible
for the size differences we observe.  These data suggest that early life is a
critical period for the setting of growth parameters that will be maintained
through adulthood.  Indeed, the role of imprinted genes in growth has been
well established, and epigenetic modifications are therefore implicated in the
same pathways.  But, the role of epigenetic modifiers independent of
imprinted genes in the production of phenotypes is just beginning to be
understood.  Epigenetic marks are by nature plastic, and are affected by such
ubiquitous factors as dietary factors and environmental components, and
could represent an additional layer of genomic sensitivity and enhanced
adaptability.  More generally, how have epigenetic marks shaped
evolutionary processes in ways undetectable by genomic scans searching
sequence data for signatures of selection and molecular evolution?
Our second set of data focused on the role of Rasgrf1 in early learning
and memory, using an olfactory associative odor-learning assay.  Neonatal
mice were tested for their ability to learn and remember an introduced
maternal odor – and once again, performance on the task depended critically
on the amount of Rasgrf1 present in brain structures at P8.  However, unlike
the results from the growth assays, the two monoallelically-expressing
genotypes behaved differently from one another.  We hypothesized that this
discrepancy was due to the mutant tm2 allele’s inability to completely
recapitulate wild-type patterns of expression, and this was found to be true, as
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tm2-derived levels of expression at P8 were significantly different from wild-
type levels.  However, varying the inheritance of the tm2 allele did not
produce different phenotypes – maternal and paternal tm2 transmission
produced the same discrepancy in performance during the associative odor
learning task, as well as similar results in transcript quantity.  This pattern
indicates that once again – at least at the Rasgrf1 locus – the level of imprinted
gene expression is critical for the production of phenotypes dependent on
imprinted genes – and that the “acceptable” threshold may vary by system.
The permanency of the differences in growth (persisting through
adulthood) is offset by the flexibility of the system in allowing tm2-derived
expression to sufficiently recapitulate a wild-type phenotype.  The data from
our learning and memory study indicate that at an age earlier than that
assayed in the growth study (P8 v P11), there is a slight but significant
difference in Rasgrf1 transcript quantity between the MM and wild-type
genotypes, in some brain structures.  This difference disappears by P11, and is
still insignificant at weaning.  However, this same difference in expression
level is insufficient to produce a wild-type behavioral phenotype at P8 – but
unlike the growth phenotype, differences in learning and memory are not
detectable among genotypes in adult animals, ie – the learning and memory
deficiencies present in neonatal mice are transient, and are not observed in
adults, when all genotypes biallelically express Rasgrf1.  Perhaps the reason
the learning and memory phenotype is more sensitive to – or intolerant of –
small differences in Rasgrf1 expression level is because it IS sensitive enough
to respond to changes in expression level, in a way that is plastic and flexible
throughout life, in contrast to the growth phenotype, where parameters are set
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early and are unresponsive to later changes in Rasgrf1 expression.
Mechanistically, this flexibility could be due to neuronal differences in the
brain structures responsible for the production of each phenotype – neuronal
remodeling, reorganization, and neurogenesis occur in the hippocampus and
olfactory system in response to experience, but similar mechanisms may not
facilitate hypothalamic restructuring with maturity.  Thus, once the initial
periods of neuronal development and pruning end, responses within the
hypothalamus might be set.
Additionally, the discrepancy in sensitivity between the growth and
learning phenotypes – as it relates to wild-type and tm2-derived expression –
could be due to instances of variability in tm2-derived expression, other than
expression level, that we have not been able to rule out.  We cannot identify
whether the tm2 allele is faithfully recapitulating wild-type Rasgrf1 expression
in particular populations of cells; ie, if expression is primarily neuronal, or if
glial cells are also expressing Rasgrf1.  We see a difference in size in biallelic
mice, but biallelic and wild-type mice perform similarly in the learning
paradigm, meaning that tm2-derived expression does not augment the
phenotype.  This could be due to expression in sites or cells irrelevant for
learning that are of importance for growth, and potentially explain why the
biallelic mice present differently with respect to wild-type mice in our two
studies.  The timing of tm2-derived expression might vary as well, though this
possibility seems less likely given the dependence of growth on early
perturbations in expression level.
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These two studies have advanced our understanding of the role Rasgrf1
plays in the development of both of these phenotypes, but additional work
could be done to make the link tighter.  For example, how exactly does Rasgrf1
influence GHRH level?  Does it affect relevant transcription factors (Ikaros,
Gsh-1, CREB) that we can directly assay for activation by western blotting?
Does it affect the growth and maturation of GHRH-producing neurons in
ways that we can examine, using neurite outgrowth assays in primary
neuronal cultures from our imprinting mutants?  Or does it affect an input
further upstream of GHRH, the feedback loops responsible for regulating axis
function, or neuronal connections between relevant structures?  Can we rescue
growth deficiencies in our null mice by treating them with GHRH or GH?
Can we reduce overgrowth in our biallelic mice by inhibiting excess axis
function?  Would the effects of these treatments vary with treatment duration,
or age?  How exactly does Rasgrf1 produce differences in learning and
memory?  Are these differences due to variations in canonical signaling (Ras,
Rac) pathways?  Are they olfactory learning-specific biochemical changes?
Would we also see differences on a cellular level, with regard to neurite
outgrowth or neuronal maturation in olfactory bulb, hippocampus, and
cortex?  When precisely do differences in task performance attenuate?  Would
other learning assays be more informative?  Could we ‘rescue’ differences in
performance by augmenting affected downstream pathways?  If an antibody
specific for RasGRF1 is ever easily available, a variety of
immunohistochemical and biochemical approaches could be employed to
identify RasGRF1 interacting partners and protein localization, both on a
subcellular and structural level.  Thus, there are many questions remaining to
be answered, though the work presented here has narrowed the potential
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focus of future inquiry and augmented our understanding of the roles Rasgrf1
plays in learning and growth, as well as the importance of proper imprinted
expression and the evolution of genomic imprinting.
110
APPENDICES
V.1  PANCREATIC RASGRF1 EXPRESSION
The size phenotype we identified in our imprinting mutants (Chapter
2) could have emerged as a result of altered pancreatic function.  Several
studies have indicated the presence of Rasgrf1 expression in pancreatic tissues
(Guerrero et al., 1996; Arava et al., 1999; Font de Mora et al., 2003) notably in
the beta-cells (ß-cells) that comprise the endocrine pancreas, though
expression has also been identified in exocrine tissues.  The pancreas is a key
component in pathways regulating insulin signaling and glucose homeostasis,
and pancreatic islets contain the insulin-producing ß-cells, as well as
glucagon-producing alpha-cells, and several other cell types.  The exocrine
(acinar) pancreas produces digestive enzymes that are released into the small
intestine.  We initially considered that the pancreas might play a role when it
became apparent that the observed differences in size among our genotypes
persisted beyond the point at which Rasgrf1 becomes biallelically expressed,
suggesting that perhaps expression in a tissue other than brain might be
mediating the presentation of the phenotype.
Font de Mora et al (2003) identified a correlation between Rasgrf1
expression and circulating insulin levels, rates of lipid catabolism, signaling
via the insulin pathway, ß-cell number, and function in wild-type and Rasgrf1
knockout mice. Rasgrf1 null mice were found to be hypoinsulinemic, glucose
intolerant, and leaner due to increased rates of lipid catabolism relative to
wild-type animals.  Null mice were also found to have pancreatic islets that
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contained a reduced number of ß-cells, which led to reductions in overall islet
size and area, as well as rates of proliferation and neogenesis. When islet
protein preparations from wild-type and null mice were stimulated with IGF-
1, differences in activated downstream signaling intermediates – including
Akt and ERK – were identified.  Activation of these intermediates in Rasgrf1
knockout islets was significantly reduced relative to activation in wild-type
islets, suggesting that Rasgrf1 plays a role in transducing signals in the insulin
pathway.  We therefore hypothesized that Rasgrf1 expression in pancreas
could be a critical player in the production of size differences that we observe
among biallelic, null, monoallelic maternal, and wild-type mice (Chapter 2),
by affecting the functioning of those cells responsible for insulin production
and signaling.
I attempted first to detect pancreatic Rasgrf1 expression, and
furthermore, to ask whether a) Rasgrf1 is also imprinted in pancreas, and b)
whether expression levels vary by genotype.  We hypothesized that variations
specifically in islet Rasgrf1 expression may contribute to functional variability
resulting in differences in size that correspond to the amount of Rasgrf1
expressed in islets; this pattern would be expected if expression were
imprinted in pancreas, and if the mutant tm1 and tm2 alleles behaved as they
do in brain.
Methods used to experimentally address this hypothesis included
analysis of Rasgrf1 mRNA levels derived from whole pancreatic extracts, as
well as analysis of islet-specific transcripts, both in adult and neonatal
animals.  Whole pancreas was dissected and homogenized from adult animals
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derived from B6/PWK reciprocal crosses, and RNA was reverse transcribed
into cDNA; a restriction site polymorphism distinguishes B6 from PWK-
derived Rasgrf1 transcript, so PCR analysis followed by HhaI digest allows for
identification of any parent-of-origin specific expression patterns.  RNA yield
from whole pancreas extracts was low, as the stability of transcripts in this
tissue is low.
To circumvent this problem, as well as facilitate a more specific
examination of endocrine Rasgrf1 transcript, I isolated islets from adult and
neonatal animals (derived from B6/PWK reciprocal crosses) and attempted to
both qualitatively and quantitatively assess islet Rasgrf1 transcript.  To do this,
mice were anesthetized, and the pancreas was perfused with HBSS through
the common bile duct (clamped at the liver and duodenal ends), which
facilitates survival of ß-cells during the extraction process.  The perfused
pancreas was then removed, chopped, and digested using collagenase type IV
(37C x 20min).  Tissues were spun at 4C, 800 rpm, and washed to remove
collagenase.  Digested tissue was then resuspended in 28% Ficoll, and a Ficoll
gradient was layered on top of the initial resuspension (23%, 21%, 11% Ficoll).
Centrifugation in the gradient (2250rpm, 4C, 7min) facilitates the localization
of islets at the interface between Ficoll layers, though that particular procedure
can also be accomplished by eye – with a microscope – as the morphology of
islets differs from that of acinar material.
Isolated islets were then homogenized, RNA was extracted, and cDNA
was made.  Despite repeated attempts to amplify Rasgrf1 transcript from islet
preparations, no transcript was reliably detected.  Nested PCR assays were
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developed and also failed to produce results.  To verify that usable RNA was
present, I simultaneously amplified a pancreas-specific transcript, Ins2, and
that amplification was successful.  Rasgrf1 transcript did show up after some
PCR amplification, but I couldn’t confidently rule out contamination from
brain cDNAs (used as imprinting and positive PCR controls) as the source of
bands in those lanes, since amplification was sporadic, even from the same
islet preparations.
Thus, despite attempts to determine whether pancreatic Rasgrf1
expression contributes to the growth phenotype, I was unable to do so,
suggesting that Rasgrf1 is either not expressed in pancreas, is expressed – but
at a very low (and potentially physiologically irrelevant) level, or is expressed,
but in a form that is undetectable by our PCR primers.  Additionally, the
results of the size phenotype characterization (Chapter 2) are convincing in
that they implicate the GH/IGF-1 axis as playing a primary role in the
production of proportional differences in size, with Rasgrf1 affecting neural
inputs to the axis.  IGF-1 does play a role in islet biology, and it is conceivable
that pancreatic contributions to the size phenotype are present, but they are
likely the result of differences in circulating IGF-1 levels that result from
Rasgrf1-affected upstream signaling.
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V.2  RNA IN SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY
Introduction
As the results of the behavioral analysis indicate, the tm2 allele does not
sufficiently recapitulate wild-type Rasgrf1 expression (see Chapter 3).  We
hypothesized that this discrepancy in expression could be due to the presence
of the PGK enhancer sequence inserted in place of the repeats that are
normally 3’ of the DMD (Figure V.2.1).
As PGK is a ‘housekeeping’ gene, we considered that its enhancer may
create different expression patterns throughout the brain, either with respect
Enh. DMD Pro
.
CTCF
wild-type
Enh. DMD Pro
.
CTCF
PGK Enh,
Pro/Neo/pA
tm2
♀
Ų
FIGURE V.2.1.  Schematic of the Rasgrf1 wild-type and tm2
alleles, depicting the insertion of the PGK
promoter/enhancer/pA and neo sequences in place of the
repeats.
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to cell type or structural distribution, in addition to altering expression level
relative to wild-type allele activity.  Thus, we attempted to use RNA in situ
hybridization to localize Rasgrf1 transcript within brain, with expression
derived from the wild-type and tm2 alleles, and to visualize cellular RasGRF1
localization using double-labeled immunohistochemical detection.  We hoped
that in situ hybridization would provide visible patterns of Rasgrf1 expression
on a more macrostructural level and identify any allele-specific differences in
transcript distribution.  We hoped that immunohistochemical staining would
help to identify where RasGRF1 protein is present, on a more microstructural
(subcellular) level, and that double-labeling with neuronal markers would
facilitate identification of any allele-specific differences in cell type.
Materials and Methods
In Situ Hybridization
P8 brains from wild-type, +/tm2, and null animals were dissected,
embedded, and frozen in Tissue-Tek O.C.T.© compound.  Blocks were then
mounted and crysectioned into 15uM slices, which were mounted 6/slide.
Brains were sectioned horizontally and coronally.
After sectioning, slides were fixed in 4% paraformaldehyde dissolved
in 0.1M PBS for 12min at room temperature, followed by two 1X PBS washes
(5min each).  Sections were then acetylated in triethanolamine-acetic
anhydride for 10 min (room temperature), washed twice in 1X PBS (5min),
and blocked at room temperature in hybridization buffer (0.1% Tween, 50%
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formamide, 5X SSC, 5X Denhardt’s, 5mM EDTA, 10mM NaH2PO4 pH 8.0,
50mM Tris pH 8.0, 250ug/ml salmon sperm DNA, 100ug/ml yeast RNA) for
two hours.  Slides were probed overnight at 55C, in a box containing 50%
formamide/3X SSC.  The next day, slides were washed twice in 5X SSC (65C X
15min), twice in 0.2X SSC (65C x 15min), once in 0.2X SSC (room temperature
x 15min), once in 1X B1 buffer (0.1M Tris, 0.15M NaCl; room temperature x
10min), and blocked with heat-inactivated goat serum (in B1 buffer) for 1 hour
at room temperature.  Slides were then probed with an alkaline-phosphatase-
conjugated anti-digoxigenin secondary antibody (1:3000) at 4C overnight.  On
day three, slides were washed three times with 1X B1 buffer (room
temperature x 5 minutes), twice in B3 buffer (0.1M Tris, 0.1M NaCl, 0.05M
MgCl2; room temperature x 5min), and stained using NBT-BCIP (in B3) buffer.
Slides were stained until color (purple) began to develop, then washed twice
in 1X PBS for 10min, and fixed at 4C for at least six hours.   Sense controls
were run simultaneously with antisense probes, on slides containing parallel
sections, and developed for the same length of time as antisense probes.   On
day four, slides were washed in 1X PBS (room temperature x 10minutes),
coverslipped, and sealed.  All reagents and glassware were RNAse free.
Probe Synthesis
Riboprobes were synthesized and targeted the portion of the Rasgrf1
transcript that does not share sequence identity with Rasgrf2.  Gene sequences
were BLASTed, and non-overlapping portions were identified.  Three probes
were designed, of varying lengths, covering two non-homologous regions,
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and sequences were cloned into pGEM TEasy vectors using T4 ligase.
Colonies were miniprepped and digested to indicate directionality of the
insert.  Remaining plasmids were then linearized, and T7 polymerase was
used to synthesize the riboprobes in a transcription reaction employing rNTPs
and digoxigenin-labeled UTP, which acts as a substrate for the anti-
digoxigenin secondary antibody.  Sense and antisense transcription reactions
were carried out for each probe, and sense probes acted as a negative control
during in situ hybridization.  Two probes were selected for further use, termed
“1A” and “1/2”.  Primer sequences used to amplify probe 1A:  (F) 5’-GTG
GTC CTG GAC AAG CTG AT-3’; (R) 5’-GTG TTG GCC AAA GAC ATC CT-
3’.  Primer sequences used to amplify probe “1/2”: (F) 5’-CTG TAC GGA GAT
GCC CCT AA-3’; (R) 5’-TCG AAG GGC TCA GTC TTC AC-3’.
Immunohistochemistry
For IHC analysis, brains from biallelic and null P8 animals (to use as
controls) were formalin-fixed, paraffin-embedded, and sectioned using the
College of Veterinary Medicine’s histology lab.  Two sections were placed on a
slide, so that positive and negative controls could be run simultaneously.
Slides were then processed by Patricia Fisher (in the Immunopathology
Research and Development Laboratory) using anti-RasGRF1 antibody (sc-224;
Santa Cruz Biotechnology[SCBT]) anti-neuron-specific enolase (NSE, which
specifically labels neuronal cytoplasm; DAKO A587), and anti-MAP2
(microtubule-associated protein, which labels dendrites; Chemicon AB5622).
Fluorescent-conjugated secondaries were used to facilitate co-localization of
proteins.
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Results and Discussion
In Situ Hybridization
Wild-type brains (Figure V.2.2, a-d) stained well, with clearly distinct
populations of Rasgrf1-expressing cells.  Sense controls displayed no staining
(Figure 2e).  +/tm2 brains also produced clear patterns of Rasgrf1 staining
with antisense probes (Figure V.2.3a-d).  Sense probes produced no staining
(Figure V.2.3e).
In addition to staining wild-type and +/tm2 brains, I also stained P8
null brains from animals that had been verified to be unmethylated at the tm1
DMD.  These brains produced staining patterns very similar to those observed
in the wild-type and +/tm2 animals (Figure V.2.4), suggesting that despite my
attempts to generate a Rasgrf1-specific probe, I was working with a probe that
identified non-Rasgrf1 transcripts.  I re-aligned my probe sequences against
the mouse genome and retrieved the same results I had earlier – by my best
estimation, the sequences I was targeting were unique to Rasgrf1.  At this
point, we decided that more convincing results might be obtained by pursuing
transcript quantification within brain structures, and the focus of this work
shifted toward that.
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Wild-type cerebellum, probe 1A Wild-type hippocampus, probe 1A
A B
Wild-type olfactory bulb,  probe 1/2 Wild-type olfactory bulb, probe 1/2
C D
Wild-type, sense probe
E FIGURE V.2.2.  In situhybridization images using probes
for Rasgrf1 in P8 wild-type brains.
Brains were sectioned either
coronally (a, b) or horizontally (c, d)
and probed with dig-labeled
antisense riboprobes (a-d).  Sense
probes (e) were used as controls for
nonspecific staining.
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+/tm2 cerebellum, probe 1A +/tm2 hippocampus, probe 1/2
A B
+/tm2 olfactory bulb, probe 1/2 +/tm2 olfactory bulb, probe 1/2
+/tm2 olfactory bulb, sense probe
C D
E
FIGURE V.2.3.  In situ hybridization
of images using probes for Rasgrf1 in
P8 +/tm2 brains.  Brains were
sectioned either coronally (a, b) or
horizontally (c, d) and probed with
dig-labeled antisense riboprobes (a-
d).  Sense probes (e) were used as
controls for nonspecific staining.
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Null hippocampus, sense probeNull hippocampus, probe 1A
A B
Null olfactory bulb, sense probeNull olfactory bulb, probe 1A
C D
FIGURE V.2.4.  In situ hybridization of images using probes for Rasgrf1 in
P8 null brains.  Brains were sectioned horizontally and probed with dig-
labeled antisense riboprobes (a, c).  Sense probes (b, d) were used as
controls for nonspecific staining, and demonstrate that the staining seen in
null brains is indeed specific.
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Should one attempt to repeat in situ hybridization in the future,
improvements on the protocol could be made by re-synthesizing probes (as
the ones I made will be several years old at that point), increasing the
stringency of the hybridization and wash conditions, and RNAse-treating
sections post-hybridization to remove any background probe.  Alternatively,
one might wish to switch to fluorescent in situ hybridization, where there is no
colorimetric reaction step, which removes some of the subjectivity in
detection.
Immunohistochemistry
Brains from biallelic and null mice were processed with antibodies
allowing for colocalization of RasGRF1 with neuronal markers, using
fluorescence-conjugated secondaries.  Initially, IHC protocols worked very
well, producing images suggesting that RasGRF1 is present in neuronal
cytoplasm (Figure V.2.5).  However, when null brains were processed as
negative controls, RasGRF1 signal was again identified (Figure V.2.6), similar
to the result we had obtained when processing the in situ hybridizations.  The
addition of blocking peptide to the protocol indicated that the signals we were
seeing were in fact due to antibody-antigen recognition, and we not the result
of nonspecific antibody activity (figure V.2.6), suggesting either that the
supplied RasGRF1 antibody was not RasGRF1-specific, or that our null brains
were not actually null.
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FIGURE V.2.5.  IHC images produced by double-labeling P8 biallelic
hippocampal coronal sections with RasGRF1 and NSE antibodies.
RasGRF1 is labeled in green, and NSE is in red.  Colocalization of the two
antibodies is present in the orange areas.
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FIGURE V.2.6.  Biallelic (a, b) and null (c, d) coronal sections probed with
RasGRF1 antibody (green).  Sections in (b) and (d) were treated with
blocking peptide, which removed the fluorescence associated with
RasGRF1 antibody recognition.
A B
C D
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I verified that the brains submitted were unmethylated, thus no
RasGRF1 should be present at the age assayed.  Upon more extensive review
of the antibody purchased, we concluded that it cross-reacted to a degree with
RasGRF2 (FIGURE V.2.7), which is the likely source for the presence of
antibody signal in the null brains.
RasGRF1
RasGRF2
Antibody:
sc-224
old lot
sc-224
new lot sc-863
FIGURE V.2.7.  Western blots demonstrating cross-
reactivity of RasGRF1 antibodies with RasGRF2.
Three different antibodies were tested: sc-224
(original lot), sc-224 (new lot), and a third antibody
from SCBT, sc-863.  All antibodies produced cross-
reactivity.  Brains from wild-type animals were used
for protein preparations.   (figure, Krista Kauppinen)
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As part of this process, we reviewed the citations provided by Santa
Cruz Biotechnology for the antibody purchased (RasGRF1 C-20, sc-224) :Tian
& Feig, 2006, reported cross-reaction of the same antibody with other RasGRF
family members; Baldassa et al., 2007, reported cross reaction of the same
antibody with RasGRF2 (see figure 2 in paper); Forlani et al., 2006, reported
cross reaction with RasGRF2 (see figure 1 in paper); Tian et al., 2004, reported
cross reaction with RasGRF2 (see figure 1 in paper).  Essentially, the only
studies not reporting cross-reactivity were those in which RasGRF1 was
transfected into cell lines, where RasGRF2 might not be present endogenously.
As such, this particular approach to studying the subcellular distribution of
wild-type and tm2-derived RasGRF1 protein will be difficult until a truly
specific primary antibody is available.
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